Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             875 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abnormal Pulmonary Function Tests Contraindicates Heart Transplant Kafi, A.
 2014
 33 4S p. S141-S142
2 p.
 artikel
2 ABO-Incompatible Adult Heart Transplantation. A Registry Study Bergenfeldt, H.
 2014
 33 4S p. S89-S90
2 p.
 artikel
3 Acidic Gastroesophageal Reflux and Aspiration Are Not Associated with Earlier Development of Bronchiolitis Obliterans in Pediatric Lung Transplant Towe, C.
 2014
 33 4S p. S286-S287
2 p.
 artikel
4 A CNI-Free, Everolimus Based Regimen in De-Novo Heart Transplant Recipients Increases Albuminuria But Improves Glomerular Filtration Rate Compared With Conventional Immunosuppression Gustafsson, F.
 2014
 33 4S p. S281-
1 p.
 artikel
5 A Combined-biomarker Approach To Phenotyping Renal Dysfunction in Heart Failure Cheng, S.J.
 2014
 33 4S p. S39-S40
2 p.
 artikel
6 A Comparison of the Extended-Release and Standard-Release Formulations of Tacrolimus in De Novo Heart Transplant Recipients: A 12-Month Outcome Study Gonzalez-Vilchez, F.
 2014
 33 4S p. S172-
1 p.
 artikel
7 A Contemporary Analysis of Early Outcomes Following Lung Transplantation in the Elderly Using a National Registry: Growing Finer with Time Hayanga, A.J.
 2014
 33 4S p. S137-S138
2 p.
 artikel
8 Activation of Copeptin, MRpro-ANP and MRpro-ADM in Heart Failure and Post LVAD and Heart Transplantation Zabarovskaja, S.
 2014
 33 4S p. S275-
1 p.
 artikel
9 Acute Fibrinous and Organizing Pneumonia is a Common Histological Pattern of Acute Lung Injury in Patients Developing Restrictive Allograft Syndrome Karimi, S.
 2014
 33 4S p. S112-S113
2 p.
 artikel
10 Acute Rejection and Graft Failure Drive Worse Outcomes Among Peripartum Cardiomyopathy (PPCM) Patients Undergoing Heart Transplant (HT) in the US: A UNOS Analysis Jacoby, D.
 2014
 33 4S p. S67-
1 p.
 artikel
11 A Descriptive Study Examining Post Lung Transplantation: Patient Employment Status, Restricting Factors for Work, and Support Requirements Scott, K.
 2014
 33 4S p. S221-S222
2 p.
 artikel
12 Adverse Effects of Interstitial Pulmonary Edema on Pulmonary Hemodynamics and Right Heart Function in Heart Failure Melenovsky, V.
 2014
 33 4S p. S53-
1 p.
 artikel
13 A Genetic Polymorphism in IL-23 Receptor Is Protective for Primary Graft Dysfunction Somers, J.
 2014
 33 4S p. S138-S139
2 p.
 artikel
14 Age-Related Decline in Lung Function in Patients Without CLAD After Double Lung Transplantation Schultz, H.L.
 2014
 33 4S p. S190-
1 p.
 artikel
15 Aggressive Early Control of Blood Pressure May Prevent Development of Significant Aortic Regurgitation Following Continuous-Flow Left Ventricular Assist Device Implantation Patil, N.P.
 2014
 33 4S p. S132-S133
2 p.
 artikel
16 Aging With a New Heart: Long Term Clinical Outcome and Quality of Life After Transplantation in Old Patients Sponga, S.
 2014
 33 4S p. S283-S284
2 p.
 artikel
17 Airway Alterations in Chronic Lung Allograft Dysfunction Verleden, S.E.
 2014
 33 4S p. S105-S106
2 p.
 artikel
18 Alloantigen Specific Immunosuppression by Induced Regulatory T Cells in Humans Boer, K.
 2014
 33 4S p. S257-
1 p.
 artikel
19 Allosensitization after Ventricular Assist Device Does Not Impact Post-Transplant Survival Thomas, T.O.
 2014
 33 4S p. S303-
1 p.
 artikel
20 Allosensitization Increases the Risk of Death on the Lung Transplant Waiting List Witt, C.A.
 2014
 33 4S p. S299-
1 p.
 artikel
21 A Longitudinal Examination of Quality of Life and Survival Long-term after Heart Transplantation White-Williams, C.
 2014
 33 4S p. S33-
1 p.
 artikel
22 Ambulatory Extracorporeal Membrane Oxygenation with Right Atrium to Pulmonary Artery Cannulation Through Hemisternotomy for Long-term Support Song, T.H.
 2014
 33 4S p. S249-
1 p.
 artikel
23 Amiodarone Treatment Prior to Heart Transplantation Is Associated with Acute Graft Dysfunction and Early Mortality: A Propensity-Matched Comparison Yerebakan, H.
 2014
 33 4S p. S105-
1 p.
 artikel
24 A Mouse Model for ABO-Incompatible Transplantation (ABOi Tx): Study of Antibody-Mediated Rejection (AMR) Motyka, B.
 2014
 33 4S p. S258-
1 p.
 artikel
25 Analysis of Incidence and Risk Factors for Polyomavirus Infection after Lung Transplant Adams, B.
 2014
 33 4S p. S180-
1 p.
 artikel
26 A New Outpatient Surveillance Program Improves Home Based Care in Long Term LVAD Recipients Woods, A.
 2014
 33 4S p. S221-
1 p.
 artikel
27 An Extended Cold Ischemic Period After Normothermic Ex Vivo Lung Perfusion Does Not Impair Lung Function in a Pig Lung Transplant Model Hsin, M.K.
 2014
 33 4S p. S48-
1 p.
 artikel
28 Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin- Receptor Blockers (ARBs) during CF-LVAD Support Are Associated with Sustained Improvement in Renal Function Saeed, O.
 2014
 33 4S p. S59-S60
2 p.
 artikel
29 An Immunohistological Study To Evaluate the Role of Eosinophils in Chronic Lung Allograft Dysfunction Vandermeulen, E.
 2014
 33 4S p. S107-
1 p.
 artikel
30 An International Tutorial for Cardiac Acute Cellular Rejection Yoshizawa, S.
 2014
 33 4S p. S314-S315
2 p.
 artikel
31 A Novel Allele-Based Measure of HLA Mismatch Predicts Treated Rejection After Heart Transplant Kransdorf, E.P.
 2014
 33 4S p. S144-S145
2 p.
 artikel
32 A Novel Diagnostic Assay for Pulmonary Antibody Mediated Rejection - Detection of Circulating Donor Tissue-Specific B Cells Yerkovich, S.
 2014
 33 4S p. S69-
1 p.
 artikel
33 A Novel Model to Predict the Risk of Non-Surgical Bleeding Among Patients Receiving Continuous Flow Left Ventricular Assist Devices Wever-Pinzon, J.
 2014
 33 4S p. S22-
1 p.
 artikel
34 Anticoagulation for the HeartWare HVAD: An International Comparison of Strategies and Outcomes Jennings, D.L.
 2014
 33 4S p. S313-S314
2 p.
 artikel
35 Anti-factor Xa Levels Versus Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin in Patients with Continuous Flow Left Ventricular Assist Devices Yarmohammadi, H.
 2014
 33 4S p. S23-S24
2 p.
 artikel
36 Antithymocyte Globulin But Not Basiliximab Is Beneficial After Infant Heart Transplantation - Analysis of the UNOS Database Coleman, B.
 2014
 33 4S p. S123-
1 p.
 artikel
37 Antithymocyte Globulin Therapy for Chronic Lung Allograft Dysfunction Following Lung Transplantation George, E.
 2014
 33 4S p. S312-
1 p.
 artikel
38 Aortic Valve Pathology in Patients Supported by a Continuous-Flow Left Ventricular Assist Device Saito, T.
 2014
 33 4S p. S195-
1 p.
 artikel
39 A Patient-Centric Conceptual Framework for Health-related Quality of Life in Mechanical Circulatory Support Grady, K.L.
 2014
 33 4S p. S33-S34
2 p.
 artikel
40 A Peritransplant Strategy in Lung Transplant Recipients with Preformed HLA Donor-Specific Antibodies (pDSA) Parquin, F.
 2014
 33 4S p. S192-S193
2 p.
 artikel
41 Apoptosis and Expression of Inducible Nitric Oxide Synthase in Normothermic Lung Perfused With Organ Care System (OCS) Compared To Standard Cold Storage Donor Lungs Calabrese, F.
 2014
 33 4S p. S256-
1 p.
 artikel
42 A Porcine Model of Chronic Right Ventricular Pressure Overload: Pulmonary Hemodynamics Over 16 Weeks, and Effects of Acute Enbucrylate Embolisation Boulate, D.
 2014
 33 4S p. S310-
1 p.
 artikel
43 A Positive Left Atrial Pressure Is Important During Ex Vivo Lung Perfusion Linacre, V.
 2014
 33 4S p. S27-S28
2 p.
 artikel
44 A Quantitative Assessment of Life with a Left Ventricular Assist Device: Questionnaires, Domains and Format Sandau, K.E.
 2014
 33 4S p. S301-
1 p.
 artikel
45 A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Study of Rabbit ATG in the Prophylaxis of Acute Rejection in Lung Transplantation Snell, G.I.
 2014
 33 4S p. S68-S69
2 p.
 artikel
46 A Randomized Trial of Everolimus Initiation and Calcineurin Inhibitor (CNI) Elimination in Stable Heart Transplant Recipients With Impaired Renal Function Derthoo, D.
 2014
 33 4S p. S14-S15
2 p.
 artikel
47 Are There Indirect Effects of Cytomegalovirus Infection? Utility of Valganciclovir. EPICA Study Sanchez-Lazaro, I.
 2014
 33 4S p. S105-
1 p.
 artikel
48 A Simple Risk Score To Predict Long-term Renal Dysfunction Following Lung Transplantation: It’s Not Over at 5 Years Hayanga, A.J.
 2014
 33 4S p. S296-
1 p.
 artikel
49 A Simplified Scoring System To Predict Post Operative Length of Stay in Mechanical Circulatory Support-A Multi-institutional Analysis Bansal, S.
 2014
 33 4S p. S211-
1 p.
 artikel
50 A Single Center Experience in the Use of Eurotransplant Donor Scoring on Donor Lung Utilization Mahoney, E.
 2014
 33 4S p. S270-S271
2 p.
 artikel
51 A Single Center Experience With Bi-Caval Dual-Lumen Canulation in Veno-Venous Extracorporeal Life Support Cunningham, V.
 2014
 33 4S p. S287-
1 p.
 artikel
52 Assessing Performance of Human Donor Hearts Following Donation After Circulatory Death Rosenfeldt, F.
 2014
 33 4S p. S104-
1 p.
 artikel
53 Assessment of Blood Pressure Measurements in Patients with Continuous Flow Left Ventricular Assist Devices: Arterial Line vs. Doppler Opening Pressure vs. Double-Cuff Oscillatory Sphygmomanometer Masood, M.F.
 2014
 33 4S p. S216-S217
2 p.
 artikel
54 Assessment of Medication Regimen Complexity Over Time Following Heart Transplantation Bryant, B.M.
 2014
 33 4S p. S312-S313
2 p.
 artikel
55 Assessment of Myocardial Performance During Ex Vivo Heart Perfusion White, C.W.
 2014
 33 4S p. S119-S120
2 p.
 artikel
56 Assessment of Right Ventricular Adaptability to Loading Conditions Can Improve the Timing of Listing to Transplantation in Patients with Pulmonary Arterial Hypertension Dandel, M.
 2014
 33 4S p. S93-S94
2 p.
 artikel
57 Assessment of the LVAD Inflow Cannula Position by Cardiac CT Ghafourian, K.
 2014
 33 4S p. S200-
1 p.
 artikel
58 Association Between Plasma Level of Soluble Receptor for Advanced Glycation and End Products and Biomarkers of Cardiac Allograft Vasculopathy in Heart Recipients Shevchenko, O.P.
 2014
 33 4S p. S261-
1 p.
 artikel
59 Association Between Steroids Withdrawal During the First Year After Heart Transplantation and Changes in Body Mass Index in a Two Year Follow-Up. RESTCO Study Crespo-Leiro, M.G.
 2014
 33 4S p. S179-
1 p.
 artikel
60 Association Between Steroids Withdrawal During the First Year After Heart Transplantation and Changes in Total Cholesterol and Its Fractions in a Two Year Follow-Up. RESTCO Study Crespo-Leiro, M.G.
 2014
 33 4S p. S282-
1 p.
 artikel
61 Association of Systemic Vascular Resistance and Right Ventricular Failure Following Left Ventricular Assist Device Implantation Keshmiri, H.
 2014
 33 4S p. S86-
1 p.
 artikel
62 Asymptomatic Cytomegalovirus Viremia Is Associated With Increasd Risk of Pneumocystis and Fungal Infections Poglajen, G.
 2014
 33 4S p. S181-S182
2 p.
 artikel
63 A Time-Dependent Model of Survival for Adverse Events in Bridge To Transplant Patients Bansal, S.
 2014
 33 4S p. S214-
1 p.
 artikel
64 Atrial Arrhythmias Following Lung Transplantation: Incidence and Risk Factors in 658 Lung Transplant Recipients D’Cunha, J.
 2014
 33 4S p. S187-
1 p.
 artikel
65 Atrial Fibrillation in Patients Supported by Continuous-Flow Left Ventricular Assist Device Garan, A.R.
 2014
 33 4S p. S193-S194
2 p.
 artikel
66 Axial Flow LVAD Support Leads to Increases in Effective Arterial Elastance by Ventriculo-Arterial Uncoupling Daniels, Z.
 2014
 33 4S p. S143-
1 p.
 artikel
67 A 2-Year Experience of Donor Evaluation for Lung Transplantation in Moscow (Russian Federation) Golovinskiy, S.V.
 2014
 33 4S p. S265-
1 p.
 artikel
68 A Zero 90-Day Mortality After Lung Transplantation - What Is the Price? Zemtsovski, M.
 2014
 33 4S p. S127-S128
2 p.
 artikel
69 Balloon Atrial Septostomy in Pulmonary Arterial Hypertension: Effect on Survival and Associated Outcomes Chiu, J.S.
 2014
 33 4S p. S93-
1 p.
 artikel
70 Banding of Right Ventricular Assist Device (RVAD) of Outflow Conduit: Is It Really Necessary With Current Devices? Lo, C.
 2014
 33 4S p. S238-
1 p.
 artikel
71 Beginners Report: Lung Transplantation Program in Szczecin, Poland Kubisa, B.
 2014
 33 4S p. S266-
1 p.
 artikel
72 Belatacept as Primary Immunosuppression in a Lung Transplant Recipient Ong, P.
 2014
 33 4S p. S31-
1 p.
 artikel
73 Benefits of an Intra-aortic Cardiorenal Support Pump in Chronic Heart Failure Clifton, W.
 2014
 33 4S p. S252-
1 p.
 artikel
74 Beta-Blocker Therapy Is Not Associated with Adverse Outcomes in Pulmonary Arterial Hypertension Thenappan, T.
 2014
 33 4S p. S230-
1 p.
 artikel
75 Bile Acid, Not pH Probe or Gastrin Predicts Allograft Function at One Year, From the Prospective RESULT (Reflux Surgery in Lung Transplantation) Davis, D.
 2014
 33 4S p. S41-S42
2 p.
 artikel
76 Bile Acids in Bronchial Wash: A Biomarker of Aspiration in the Donor and Recipient? Nakajima, D.
 2014
 33 4S p. S184-
1 p.
 artikel
77 Biomechanics of Right Ventricular Myocardial Remodeling in Response to Pressure Overload Simon, M.A.
 2014
 33 4S p. S228-S229
2 p.
 artikel
78 Blood Pressure Profiles of Patients with Left Ventricular Assist Devices Campbell, P.T.
 2014
 33 4S p. S217-
1 p.
 artikel
79 Blood Test to Monitor for the Absence of Acute Cardiac Rejection: From Discovery to Clinical Implementation Hollander, Z.
 2014
 33 4S p. S26-
1 p.
 artikel
80 Brachial Vein Right Heart Access: A Comparative Analysis of >1100 Cases Harwani, N.
 2014
 33 4S p. S52-S53
2 p.
 artikel
81 Bridging Infants <5 kg: Should We Continue To Offer ECMO? Villa, C.R.
 2014
 33 4S p. S303-
1 p.
 artikel
82 Bronchial Artery Revascularization and En Bloc Lung Transplant in Children Guzman-Pruneda, F.
 2014
 33 4S p. S290-
1 p.
 artikel
83 B-Type Natriuretic Peptide Profiles in the Setting of Chronic Left Ventricular Assist Device Support Krim, S.R.
 2014
 33 4S p. S236-
1 p.
 artikel
84 Canadian Society of Transplantation (CST) Members’ Views on Anonymity in Organ Transplantation Gewarges, M.
 2014
 33 4S p. S309-
1 p.
 artikel
85 Can a Minimally Invasive OFF-pump Implantation Strategy be Considered Safe for Selected Patients Undergoing HeartWare Ventricular Assist Device Implantation? Sileshi, B.
 2014
 33 4S p. S58-
1 p.
 artikel
86 Can Avoiding Sternotomy Reduce Early Complications of Left Ventricular Assist Device Surgery? Observations from Routine Implantation of Heartmate II Left Ventricular Assist Device without Median Sternotomy Anyanwu, A.C.
 2014
 33 4S p. S202-
1 p.
 artikel
87 Can Body Mass Index Identify Patients at Risk for Right Ventricular Failure after LVAD Placement? Bhama, J.K.
 2014
 33 4S p. S237-
1 p.
 artikel
88 Candidate Gene Association Study in BOS Diamond, J.M.
 2014
 33 4S p. S139-S140
2 p.
 artikel
89 Can Persistent Bleeding in HeartMate II Patients Be Safely Managed with Reduced Anti-thrombotic Regimens? Preliminary Results from the US-TRACE Study Katz, J.N.
 2014
 33 4S p. S10-S11
2 p.
 artikel
90 Can the Severity of Post-operative Bleeding Events be Predicted from Von Willebrand Factor Dysfunction in Continuous Flow Left Ventricular Assist Device Recipients? Tricarico, N.M.
 2014
 33 4S p. S245-
1 p.
 artikel
91 Can We Define a Device-specific Profile for Acquired Von Willebrand Syndrome in Continuous Flow Left Ventricular Assist Device Recipients? Tricarico, N.M.
 2014
 33 4S p. S23-
1 p.
 artikel
92 Cardiac Arrest in the Era of Mechanical Circulatory Support: A Single Center Experience with Extracorporeal Cardiopulmonary Resuscitation Truby, L.
 2014
 33 4S p. S249-
1 p.
 artikel
93 Cardiac CT Parameters as Predictors of Aortic Insufficiency Post LVAD Implantation Kancherla, K.
 2014
 33 4S p. S195-S196
2 p.
 artikel
94 Cardiac Metabolism Gene Expression Differences in Patients With Advanced Ischemic Versus Non-Ischemic Cardiomyopathy Yen, C.
 2014
 33 4S p. S40-
1 p.
 artikel
95 Cardiac MRI of Heart Transplant Recipients With Previous CMV Infection Demonstrates Ventricular Hypertrophy and Dysfunction Butler, C.
 2014
 33 4S p. S136-
1 p.
 artikel
96 Cardiac Retransplantation: A Case Report in a Patient With Acute Reactivation of Chagas Disease Ferraz, D.L.
 2014
 33 4S p. S263-
1 p.
 artikel
97 Cardiac Retransplantation: How Far Have We Come? DePasquale, E.C.
 2014
 33 4S p. S66-
1 p.
 artikel
98 Cardiac Transplantation in Children with Chromosomal Anomalies: A Multi-Institutional Outcomes Analysis Shamszad, P.
 2014
 33 4S p. S303-S304
2 p.
 artikel
99 Cardiomyocyte p65 NF-kB Is Necessary for Compensatory Adaptation To Pressure-Overload Javan, H.
 2014
 33 4S p. S273-
1 p.
 artikel
100 Cardiovascular MRI Imaging Independently Predicts Adverse Cardiovascular Events in Heart Transplant Recipients Butler, C.
 2014
 33 4S p. S136-S137
2 p.
 artikel
101 Carfilzomib for Refractory Antibody Mediated Rejection and Allosensitization in Heart Transplantation Sacha, L.
 2014
 33 4S p. S31-
1 p.
 artikel
102 Case Report of Cardiac Allografts Retrieved From Human Donation After Circulatory Death (DCD) Donors - Assessment on Ex Vivo Beating Heart Perfusion Device Iyer, A.
 2014
 33 4S p. S119-
1 p.
 artikel
103 Catheter-directed Intrapleural Fibrinolysis for Complicated Pleural Effusion Following Lung Transplantation - A Safe and Effective Strategy Shigemura, N.
 2014
 33 4S p. S292-
1 p.
 artikel
104 CDC “High Risk” Donor Status Does Not Significantly Effect Patient Outcome in Pediatric Heart Transplantation Sahulee, R.
 2014
 33 4S p. S225-S226
2 p.
 artikel
105 C4d Deposition is a Marker for Pan Cardiac Vasculopathy after Heart Transplantation Hiemann, N.E.
 2014
 33 4S p. S124-
1 p.
 artikel
106 CD25+ Regulatory T Cells in Bronchoalveolar Lavage Fluid Are Associated with Lung Allograft Rejection Greenland, J.R.
 2014
 33 4S p. S300-
1 p.
 artikel
107 Cellular Ca2+ Handling in Cardiac Atrophy and Hypertrophy Schwoerer, A.P.
 2014
 33 4S p. S234-
1 p.
 artikel
108 Centrifugal Ventricular Assist Device Flow Rates <3L/min Is Predictive of Thrombotic Complications in Pediatric Patients Holzer, S.M.
 2014
 33 4S p. S19-
1 p.
 artikel
109 Cerebrovascular Accidents and End of Life Admissions Contribute Most to the Cost in Patients With Continuous Flow Left Ventricular Assist Devices Ashrith, G.
 2014
 33 4S p. S196-
1 p.
 artikel
110 Challenges to Lung Recovery from Sudden Death Victims to Assess Suitability for Transplant, and Strategies to Address These Challenges Egan, T.
 2014
 33 4S p. S227-
1 p.
 artikel
111 Change in Acoustic Fingerprints at Increased Pump Speed During Echocardiographic Ramp Test Sundbom, P.
 2014
 33 4S p. S206-
1 p.
 artikel
112 Change in Health-related Quality of Life from Before to After Destination Therapy Mechanical Circulatory Support is Similar for Older and Younger Patients: Analyses from INTERMACS Grady, K.L.
 2014
 33 4S p. S89-
1 p.
 artikel
113 Change of Myocardial Microvascular Density under Mechanical Circulatory Support in the Failing Heart Saito, T.
 2014
 33 4S p. S143-
1 p.
 artikel
114 Changes in Left and Right Ventricular Function Before and After Lung Transplantation: Serial Echocardiographic Assessment Kato, T.S.
 2014
 33 4S p. S141-
1 p.
 artikel
115 Changes in Longitudinal Myocardial Function During Acute Cardiac Rejection: The Clinical Role of 2D Speckle Tracking Echocardiography Clemmensen, T.S.
 2014
 33 4S p. S26-
1 p.
 artikel
116 Changes in Platelet Count After Heart Mate II Insertion Implications for Rationale Use of Anti Platelet Factor IV Antibodies Alvarez, P.
 2014
 33 4S p. S243-
1 p.
 artikel
117 Changing Outcomes After Heart Transplantation in Patients with Amyloid Cardiomyopathy Davis, M.
 2014
 33 4S p. S158-S159
2 p.
 artikel
118 Characterization of Lymphoid Clusters in the Transplanted Heart; an Effort To Form Tertiary Lymphoid Clusters? Huibers, M.M.
 2014
 33 4S p. S314-
1 p.
 artikel
119 Chronic Inflammation in Heart Failure Patients with Mechanical Circulatory Support Grosman-Rimon, L.
 2014
 33 4S p. S76-S77
2 p.
 artikel
120 Chronic Intravenous Milrinone as a Bridge to Cardiac Transplantation Does Not Improve Pulmonary Arterial Compliance Kumar, A.
 2014
 33 4S p. S77-
1 p.
 artikel
121 Chronic Lung Allograft Dysfunction - A Disease of Accelerated Epithelial Ageing? Yerkovich, S.
 2014
 33 4S p. S70-S71
2 p.
 artikel
122 Circulating Adhesion Molecule in Ex-Vivo Lung Perfusion Predicts Primary Graft Dysfunction Hashimoto, K.
 2014
 33 4S p. S16-S17
2 p.
 artikel
123 Circulating Cell-Free DNA Is a Non-Invasive Marker of Heart Transplant Rejection De Vlaminck, I.
 2014
 33 4S p. S84-S85
2 p.
 artikel
124 Circulating Levels of miR-15b and miR-133b in Patients during Chronic LVAD Unloading Galenko, O.
 2014
 33 4S p. S232-
1 p.
 artikel
125 Clinical and Molecular Epidemiologic Characterization of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Occurring Early After Lung Transplant Clancy, C.
 2014
 33 4S p. S153-S154
2 p.
 artikel
126 Clinical and Prognostic Significance of Heart Rate Variability in Pulmonary Hypertension Musayev, O.
 2014
 33 4S p. S229-
1 p.
 artikel
127 Clinical Importance of Flow Cytometry Crossmatch in the Context of Complement-Dependent Cytotoxicity Crossmatch Results Following Heart Transplantation Keeshan, B.C.
 2014
 33 4S p. S84-
1 p.
 artikel
128 Clinical Observations and Outcome After Ablation of Atrial Arrhythmias in Patients With Orthotopic Heart Transplant Weston, K.L.
 2014
 33 4S p. S172-S173
2 p.
 artikel
129 Clinical Outcome of Bilateral Lung Transplantation for Cystic Fibrosis in the Frame of the European Multicentric COLT Study Lacoste, P.
 2014
 33 4S p. S183-
1 p.
 artikel
130 Clinical Outcomes in Lung Retransplantation Halloran, K.
 2014
 33 4S p. S297-
1 p.
 artikel
131 Clinical Outcomes of Multidisciplinary Team Management in Patients Supported With Left Ventricular Assist Devices Pinninti, M.
 2014
 33 4S p. S220-
1 p.
 artikel
132 Clinical Significance of Anti-HLA Antibodies Associated With Ventricular Assist Device Use in Pediatric Patients: A United Network for Organ Sharing Database Analysis Magdo, H.S.
 2014
 33 4S p. S302-
1 p.
 artikel
133 Clinical Significance of Gastroesophageal Reflux Disease and Proton Pump Inhibitor Use in Pulmonary Arterial Hypertension Ramani, G.
 2014
 33 4S p. S309-
1 p.
 artikel
134 Clopidogrel Preserves Microvascular Integrity in Orthotopic Tracheal Transplants affected by Obliterative Bronchiolitis Heim, C.
 2014
 33 4S p. S255-
1 p.
 artikel
135 CMV-Seronegative Heart Recipients Disclose a Lower Immunocompetence Status Before Transplantation in Comparison With Seropositive Patients Carbone, J.
 2014
 33 4S p. S20-S21
2 p.
 artikel
136 CNI Free Immunosuppression in Heart Transplant Patients Treated With Everolimus: Results of a Multicenter French Registry Epailly, E.
 2014
 33 4S p. S279-S280
2 p.
 artikel
137 Combination of mTOR Inhibitor and Calcineurin Inhibitor in EBV-positive and EBV-negative B-lymphocytes Schubert, S.
 2014
 33 4S p. S253-
1 p.
 artikel
138 Combined Heart and Abdominal Organ Transplantation: Excellent Outcomes Gained from a Unique Experience Stulak, J.M.
 2014
 33 4S p. S278-
1 p.
 artikel
139 Combined Short Term Caspofungin and Nebulized Amphotericin B Prophylaxis May Help To Eradicate Aspergillus Related Complications After Lung Transplantation Hammainen, P.T.
 2014
 33 4S p. S180-
1 p.
 artikel
140 Combined Thromboxane Synthase Inhibition and H2-Receptor Blockade Prevents PVR Elevation During GalTKO.hCD46.hCD55 Pig Lung Perfusion With Human Blood Burdorf, L.
 2014
 33 4S p. S257-S258
2 p.
 artikel
141 Community Acquired Respiratory Viral Infection after Lung Transplantation: BOS Risk and Risks of Specific Viruses Benzimra, M.
 2014
 33 4S p. S183-S184
2 p.
 artikel
142 Comparable Mortality and Morbidity of Orthotopic Heart Transplantation for Patients Younger and Older Than 70 Years Awad, M.
 2014
 33 4S p. S64-
1 p.
 artikel
143 Comparative Study of Left Ventricular Mechanics during Percutaneously-Delivered Circulatory Support in a Preclinical Model of Acute Left Heart Injury Paruchuri, V.
 2014
 33 4S p. S206-
1 p.
 artikel
144 Comparative Utility of Gene Expression Profiling Score Variability, Endomyocardial Biopsy, and Echocardiography to Predict Future Clinical Events in Heart Transplant Recipients Deng, M.
 2014
 33 4S p. S175-
1 p.
 artikel
145 Comparison Between Cellular and Acellular Perfusates Used During Ex-Vivo Lung Perfusion in a Porcine Model Roman, M.
 2014
 33 4S p. S16-
1 p.
 artikel
146 Comparison of Early Versus Delayed Left Ventricular Assist Device Implantation in Patients Bridged to Heart Transplantation Kitada, S.
 2014
 33 4S p. S56-
1 p.
 artikel
147 Comparison of Heart Replacement Therapy in Patients Over 65 Years Old Sorabella, R.
 2014
 33 4S p. S55-
1 p.
 artikel
148 Comparison of Heart Transplant Outcomes in Patients Who Received an Axial Versus Centrifugal Flow LVAD as Bridge to Transplant Rosner, C.M.
 2014
 33 4S p. S177-
1 p.
 artikel
149 Comparison of Listing Strategies for Allosensitized Heart Transplant Candidates: A Decision Model Analysis Feingold, B.
 2014
 33 4S p. S150-S151
2 p.
 artikel
150 Comparison of Survival between Pediatric and Adult Patients after Biventricular Assist Device Implantation: Analysis of the UNOS Database DePasquale, E.C.
 2014
 33 4S p. S57-
1 p.
 artikel
151 Comparison of Total Artificial Heart and Biventricular Assist Device Support as Bridge-to-Transplantation Cheng, A.
 2014
 33 4S p. S36-
1 p.
 artikel
152 Comparison of Voriconazole and Posaconazole Use in Lung Transplant Patients Chau, C.
 2014
 33 4S p. S292-
1 p.
 artikel
153 Complement-Fixing Donor-Specific Antibodies After Lung Transplantation Iuppa, J.A.
 2014
 33 4S p. S184-
1 p.
 artikel
154 Complement-Fixing Donor-Specific Antibody and Lung Transplant Outcomes Chhatwani, L.
 2014
 33 4S p. S160-
1 p.
 artikel
155 Complete Pulmonary Artery Occlusion from Chronic Thromboembolic Disease: Outcomes Following Pulmonary Thromboendarterectomy Surgery Kitcher, A.
 2014
 33 4S p. S54-
1 p.
 artikel
156 Concomitant Aortic Valve Procedures in Patients Undergoing Implantation of Continuous-Flow LVADs: An INTERMACS Database Analysis Robertson, J.O.
 2014
 33 4S p. S9-
1 p.
 artikel
157 Concurrent Use of Sirolimus and Voriconazole: Assessing Long Term Safety and Dosing Strategies Dang, C.V.
 2014
 33 4S p. S114-S115
2 p.
 artikel
158 Connexins: A New Target for the Prevention of Transplant Vasculopathy? Porterie, J.
 2014
 33 4S p. S163-S164
2 p.
 artikel
159 Consequences of Long-Term Anticoagulation and Antiplatelet Cessation in Patients on Bleeding Complications Tong, M.Z.
 2014
 33 4S p. S246-
1 p.
 artikel
160 Contemporary Outcome of Mechanical Circulatory Support Therapy: Analysis of Multicenter Registry, RESCUE Takayama, H.
 2014
 33 4S p. S37-
1 p.
 artikel
161 Contemporary Outcomes of Lung Transplantation in Patients with Preoperative Extracorporeal Membrane Oxygenation: A Propensity-Match Analysis Bermudez, C.
 2014
 33 4S p. S29-
1 p.
 artikel
162 Continuous-Flow Left Ventricular Assist Device Support is Associated with Aortic Valve Interstitial Cell Activation van Rijswijk, J.W.
 2014
 33 4S p. S76-
1 p.
 artikel
163 Continuous Flow Left Ventricular Assist Device Thrombosis: Presentation, Management and Outcomes Zhao, D.
 2014
 33 4S p. S242-S243
2 p.
 artikel
164 Continuous Left Atrial Pressure Monitoring Improves Outcomes in Heartmate II Patients Gosev, I.
 2014
 33 4S p. S12-
1 p.
 artikel
165 Coronary Allograft Vasculopathy in Pediatric Heart Transplant: Is Re-transplant a Prudent Option for All? Zafar, F.
 2014
 33 4S p. S111-
1 p.
 artikel
166 Coronary Angiography of Older Donor Hearts During Evaluation for Transplantation Davis, M.
 2014
 33 4S p. S161-S162
2 p.
 artikel
167 Coronary Artery Bypass Surgery or Heart Transplantation for Treatment of End-stage Ischemic Cardiomyopathy Hiemann, N.E.
 2014
 33 4S p. S169-
1 p.
 artikel
168 Coronary Vasomotor Dysfunction Indicates Non-stenotic Coronary Angiographic and Biopsy-proven Vasculopathy in Cardiac Transplant Recipients Hiemann, N.E.
 2014
 33 4S p. S133-S134
2 p.
 artikel
169 Correlation Between Post-Operative Spirometry and Donor-To Recipient Predicted Total Lung Capacity in Bilateral Lung Transplantation Rampolla, R.
 2014
 33 4S p. S269-
1 p.
 artikel
170 Correlation of Circulating Donor-Specific Anti-HLA Antibodies and Biopsy-Diagnosed Antibody-Mediated Rejection in Endomyocardial Biopsy With Cardiac Allograft Vasculopathy Sato, T.
 2014
 33 4S p. S283-
1 p.
 artikel
171 Correlation of Hemodynamics and Function Capacity in 2nd and 3rd Generation LVADs Ross, A.
 2014
 33 4S p. S207-
1 p.
 artikel
172 Correlation of Physiological Data at Ex Vivo Lung Perfusion and Reperfusion in a Rat Ischemia-Reperfusion Model Using Plasmin Motoyama, H.
 2014
 33 4S p. S255-S256
2 p.
 artikel
173 Cost Effectiveness of Detection of Tamponade After Postcardiac Surgery By Miniaturized Hemodynamic Transesophageal Echocardiogram (hTEE) Hirose, H.
 2014
 33 4S p. S128-S129
2 p.
 artikel
174 Cost Effectiveness of Routine Surveillance Endomyocardial Biopsy Beyond 12 Months Post Heart Transplantation Lampert, B.C.
 2014
 33 4S p. S45-
1 p.
 artikel
175 C1q Testing in Pediatric Heart Transplant Recipients at Risk for Antibody Mediated Rejection Albers, E.
 2014
 33 4S p. S123-
1 p.
 artikel
176 Creation of a Surgical Fontan Animal Model and the Use of a Ventricular Assist Device to Restore Cardiac Output Derk, G.R.
 2014
 33 4S p. S74-S75
2 p.
 artikel
177 Cryoanalgesia Complements Thoracic Epidural Use Following Lung Transplantation Hartwig, M.G.
 2014
 33 4S p. S290-S291
2 p.
 artikel
178 Cumulative Exposure to Medical Sources of Ionizing Radiation in the First Year After Pediatric Heart Transplantation McDonnell, A.
 2014
 33 4S p. S225-
1 p.
 artikel
179 Current Status of Heart Transplantation in the Kingdom of Saudi Arabia Selimovic, N.
 2014
 33 4S p. S264-S265
2 p.
 artikel
180 Cytomegalovirus Infection Following Lung Transplantation - Occurrence, Treatment and Risk of OB Thomas, D.
 2014
 33 4S p. S180-S181
2 p.
 artikel
181 Daily Activity in Rotary Blood Pump Recipients Granegger, M.
 2014
 33 4S p. S220-
1 p.
 artikel
182 DAP12 Expression By Lung-Resident Macrophages Mediates Pulmonary Ischemia Reperfusion Injury By Promoting Neutrophil Extravasation Spahn, J.
 2014
 33 4S p. S97-S98
2 p.
 artikel
183 DCD Lung Transplantation for Pulmonary Arterial Hypertension: Passing the Toughest Test Levvey, B.
 2014
 33 4S p. S94-S95
2 p.
 artikel
184 Decreased Renal Function Correlates With Severity of Aortic Regurgitation But Not LV EF or RV Function With LVAD Therapy Sajgalik, P.
 2014
 33 4S p. S194-
1 p.
 artikel
185 Dectection of Early Thrombus Formation in LVAD By Accoustic Fast Fourier Transformation Analysis. A Novel Approach for Monitoring von Samson, P.
 2014
 33 4S p. S130-S131
2 p.
 artikel
186 Defining Clinically Relevant CLAD Phenotypes in Bilateral and Single Lung Transplant Recipients DerHovanessian, A.
 2014
 33 4S p. S42-
1 p.
 artikel
187 Defining Prognostic Markers in Heart and Lung Transplant Recipients with PTLD Kumarasinghe, G.
 2014
 33 4S p. S84-
1 p.
 artikel
188 Delayed Sternal Closure Following Heart Transplantation: Outcomes and Implications Ali, A.A.
 2014
 33 4S p. S280-
1 p.
 artikel
189 Demographics and Outcomes from a Binational Australian and New Zealand Registry for Adults with Congenital Heart Disease and Pulmonary Arterial Hypertension Rose, M.L.
 2014
 33 4S p. S92-S93
2 p.
 artikel
190 De Novo Development of Donor Specific Antibodies To HLA Is Associated With Dysregulation of microRNA Expression Profile Affecting Immune Responses Resulting in Bronchiolitis Obliterans Syndrome Following Human Lung Transplantation Xu, Z.
 2014
 33 4S p. S160-
1 p.
 artikel
191 De Novo DQ Donor-Specific Antibodies Are Associated With Chronic Lung Allograft Dysfunction Tikkanen, J.M.
 2014
 33 4S p. S98-S99
2 p.
 artikel
192 De-Novo Low TAC/Low SIR Immunosuppression after HTx - 10 Year Results of a Prospective Trial Stroeh, K.
 2014
 33 4S p. S15-
1 p.
 artikel
193 Depression and Social Isolation at Time of Wait Listing Reduce Survival Up to 5 Years After Heart Transplantation - Results from the Waiting for a New Heart Study Spaderna, H.
 2014
 33 4S p. S126-
1 p.
 artikel
194 Depression Does Not Affect Outcomes in Patients with Left Ventricular Assist Devices Raymer, D.S.
 2014
 33 4S p. S218-S219
2 p.
 artikel
195 Detection of Invasive Pulmonary Aspergillus in Lung Transplant Patients Using a Lateral Flow Device Watson, K.
 2014
 33 4S p. S189-
1 p.
 artikel
196 Determining Eligibility for Lung Transplantation: A Nationwide Assessment of Cutoff Glomerular Filtration Rates Osho, A.A.
 2014
 33 4S p. S138-
1 p.
 artikel
197 Developing a Score of Early Postoperative Regulatory T Cell Frequency To Predict Bronchiolitis Obliterans Syndrome-Free Survival at Two Years After Lung Transplantation Salman, J.
 2014
 33 4S p. S41-
1 p.
 artikel
198 Development and Validation of a Lung Transplant-Specific Disability Questionnaire Singer, J.P.
 2014
 33 4S p. S46-
1 p.
 artikel
199 Development of a Novel Predictive Model for Mortality Post Continuous Flow LVAD Implant using Bayesian Networks (BN) Loghmanpour, N.A.
 2014
 33 4S p. S74-
1 p.
 artikel
200 Development of a Repair for Traumatic Damage to the HeartWare HVAD® Pump Driveline Graham, J.D.
 2014
 33 4S p. S102-
1 p.
 artikel
201 Development of De-Novo Aortic Valve Incompetence in Patients With the Continuous Flow Heartware® Ventricular Assist Device Bhagra, S.K.
 2014
 33 4S p. S129-
1 p.
 artikel
202 Development of Recipient-Matched Engineered Heart Tissue Using 3D Printing Yildirim, Y.
 2014
 33 4S p. S97-
1 p.
 artikel
203 Device Malfunction in Long Term Mechanical Circulatory Support Devices - A Single Centre Experience Kerk, K.
 2014
 33 4S p. S260-
1 p.
 artikel
204 Diagnostic Utility of Capsule Endoscopy in Evaluating GI Bleeding in LVAD Patients Mohammad Alahmad, M.
 2014
 33 4S p. S244-
1 p.
 artikel
205 Differences in Regional Recipient Waitlist Time and Pre- and Post-Transplant Mortality Following the 2006 UNOS Policy Changes in the Donor Heart Allocation Algorithm Kitada, S.
 2014
 33 4S p. S118-
1 p.
 artikel
206 Differential Immune Response to Gal+ and Gal- Bioprosthetic Heart Valves Byrne, G.W.
 2014
 33 4S p. S167-S168
2 p.
 artikel
207 Differential Mitochondrial Gene Expression in Patients Undergoing MCSD Implantation Chang, E.
 2014
 33 4S p. S234-S235
2 p.
 artikel
208 Differentiating Heart Failure with Preserved Ejection Fraction Induced Pulmonary Hypertension from Pulmonary Hypertension Using Demographic Data and Common Blood Measurements Salamon, J.
 2014
 33 4S p. S147-S148
2 p.
 artikel
209 Dilated Tricuspid Valve Annulus Vs. Tricuspid Regurgitation as a Predictor of Right Ventricular Failure After Left Ventricular Assist Device Implant Goldraich, L.A.
 2014
 33 4S p. S239-
1 p.
 artikel
210 Discovering Novel Inflammatory Triggers after Heart Transplantation Via Proteomics Shen, H.
 2014
 33 4S p. S164-
1 p.
 artikel
211 Distribution Pattern of Viable Resident C-Kit Positive Cardiac Stem Cells in the Human Ischemic Heart as a Pool for Cardiac Regeneration Garbade, J.
 2014
 33 4S p. S254-
1 p.
 artikel
212 Do Continuous Flow Left Ventricular Assist Devices Really Cause Allosensitization? Willis, C.A.
 2014
 33 4S p. S100-
1 p.
 artikel
213 Do Current Anti-Platelet Agents Truly Provide Protection Against Shear-Mediated Platelet Activation in Mechanical Circulatory Support? Valerio, L.
 2014
 33 4S p. S143-S144
2 p.
 artikel
214 Does Duration of Donor Cardiopulmonary Resuscitation Impact Pediatric Cardiac Graft Survival? Khan, M.S.
 2014
 33 4S p. S42-S43
2 p.
 artikel
215 Does Metabolic Syndrome Affect Outcomes After Left Ventricular Assist Device Implantation? Maltais, S.
 2014
 33 4S p. S35-
1 p.
 artikel
216 Does Postoperative Improvement in Brain Natriuretic Peptide Predict Readmission after Left Ventricular Assist Device? Haglund, N.A.
 2014
 33 4S p. S233-S234
2 p.
 artikel
217 Does Preoperative Mitral Regurgitation Influence Outcomes After Continuous-Flow Left Ventricular Assist Device Implantation? Maltais, S.
 2014
 33 4S p. S34-S35
2 p.
 artikel
218 Does Sequence Matter? Outcomes of Donors Rejected by Local Centers Baran, D.A.
 2014
 33 4S p. S268-
1 p.
 artikel
219 Does the Ability for Donor Specific Antibodies to Bind Complement Always Result in C4d Staining in the Endomyocardial Biopsy After Heart Transplant? Lipson-Altman, N.
 2014
 33 4S p. S83-
1 p.
 artikel
220 Does the Calcineurin Inhibitor Have Influence on Cytomegalovirus Infection in Heart Transplantation? Sanchez-Lazaro, I.
 2014
 33 4S p. S15-
1 p.
 artikel
221 Does the Indication for Retransplantation Following Primary Heart Transplant in Childhood Impact Outcomes? An Analysis from the International Society of Heart and Lung Transplantation Registry Conway, J.
 2014
 33 4S p. S45-
1 p.
 artikel
222 Does the Presence of Complement Binding De Novo DSA Distinguish Different Pathology Defined Rejection Patterns in Heart Transplant Recipients? Reinsmoen, N.L.
 2014
 33 4S p. S283-
1 p.
 artikel
223 Does VAD Placement Reduce Weight in Obese Severe Heart Failure Patients? Moriguchi, J.
 2014
 33 4S p. S209-
1 p.
 artikel
224 Donor and Recipient Hepatitis C Status in Lung Transplant Englum, B.R.
 2014
 33 4S p. S182-S183
2 p.
 artikel
225 Donor and Recipient Renal Dysfunction and Post Cardiac Transplant Graft Survival: Insights Into Reno-Cardiac Interactions Laur, O.
 2014
 33 4S p. S104-
1 p.
 artikel
226 Donor and Recipient Risk Factors for Early Airway Dehiscence Following Lung Transplantation Kon, Z.N.
 2014
 33 4S p. S297-S298
2 p.
 artikel
227 Donor Diabetes and Lung Transplant: Does It Matter? Haney, J.C.
 2014
 33 4S p. S50-S51
2 p.
 artikel
228 Donor Hemoglobin Is an Independent Predictor of Long-Term Outcomes in Heart Transplant - A Hypothesis Generating Preliminary Data From a Single Center Cordero-Reyes, A.M.
 2014
 33 4S p. S267-
1 p.
 artikel
229 Donor Oxygenation Has No Impact on Postoperative Outcome After Lung Transplantation Sommer, W.
 2014
 33 4S p. S271-
1 p.
 artikel
230 Donor Single-dose Treatment with VEGFR-3 Antibody Reduces Acute Alloimmune Response by Targeting Lymphatic Endothelial Cell Activation Dashkevich, A.
 2014
 33 4S p. S165-
1 p.
 artikel
231 Donor-Specific HLA Alloantibodies: Impact on Cardiac Allograft Vacsulopathy and Survival After Pediatric Heart Transplantation Tran, A.
 2014
 33 4S p. S151-
1 p.
 artikel
232 Donor Surfactant Protein A2 Gene Polymorphisms Are Associated With Early Lung Transplant Survival Aramini, B.
 2014
 33 4S p. S139-
1 p.
 artikel
233 Donor Treatment with N-Octanoyl Dopamine in Brain-Dead Rats Improves Both Donor and Graft Left Ventricular Function After Heart Transplantation Szabo, G.
 2014
 33 4S p. S120-
1 p.
 artikel
234 Do Redo Heart Transplant Patients Have an Increased Risk of Antibody Development? Kittleson, M.
 2014
 33 4S p. S284-
1 p.
 artikel
235 Dried Blood Spot Monitoring After Lung Transplantation: Patients Perspectives Wessels-Bakker, M.J.
 2014
 33 4S p. S221-
1 p.
 artikel
236 Driveline Infection After HeartMate II Is Associated with Lower Rates of Cardiac Transplantation and Longer Transplant Waiting Times in the Bridge to Transplant Population Harvey, L.
 2014
 33 4S p. S197-
1 p.
 artikel
237 Dual Ex Vivo Lung Perfusion Techniques Ameliorate Airway Hypoxia in Lung Grafts in Rats Tanaka, Y.
 2014
 33 4S p. S27-
1 p.
 artikel
238 Durable Improved Diabetic Control Up to 24 Months After Implantation of Left Ventricular Assist Device Davis, J.D.
 2014
 33 4S p. S208-S209
2 p.
 artikel
239 Dynamic Changes in Proteinuria Identify a Form of Cardiorenal Dysfunction Associated with Decreased Survival: An Application of the SOLVD Trial Limited Dataset Brisco, M.A.
 2014
 33 4S p. S171-
1 p.
 artikel
240 Early Ambulation as a Predictor of Length of Stay and Discharge to Home Following LVAD Implantation Shoemaker, M.J.
 2014
 33 4S p. S213-
1 p.
 artikel
241 Early Downregulation of Innate NK Cell Reponses By Post-Transplant Blocking of VEGF Receptors Attenuates Experimental Obliterative Airway Disease in Mice Krebs, R.
 2014
 33 4S p. S82-S83
2 p.
 artikel
242 Early Identification of Impending LVAD Thrombosis Utilizing an Ultra-High Predictive Serum Marker in Lactate Dehydrogenase Zalewski, C.M.
 2014
 33 4S p. S242-
1 p.
 artikel
243 Early Immune Monitoring After Cardiac Transplantation Predicts Progression of Maximal Intimal Thickness by Intravascular Ultrasound Cheng, R.
 2014
 33 4S p. S24-
1 p.
 artikel
244 Early Progression of Pulmonary Edema Predicts Mortality in Patients With Extracorporeal Life Support - A Prospective Study Westenfeld, R.
 2014
 33 4S p. S251-
1 p.
 artikel
245 Echocardiographic Features and Utility of Baseline Echo in the Assessment of Pulmonary Hypertension in Patients with Atrial Septal Defect Abernethy, A.
 2014
 33 4S p. S93-
1 p.
 artikel
246 Effectiveness of Continuous Flow Left Ventricular Assist Device Exchange for Recurrence of Major Drive Line and Pump Pocket Infection Masood, M.F.
 2014
 33 4S p. S196-S197
2 p.
 artikel
247 Effect of Continuous-Flow LVADs on Pulmonary Arterial Pressure: Comparison Between Axial and Centrifugal Flow Devices Jumean, M.F.
 2014
 33 4S p. S237-
1 p.
 artikel
248 Effect of CYP3A4*22 and CYP3A5 Combined Genotypes on Tacrolimus Disposition in Heart Transplantation Vu, A.
 2014
 33 4S p. S115-S116
2 p.
 artikel
249 Effect of CYP2C9 and VKORC1 Gene Variants in Determining the Maintenance of Warfarin Dose and Complications in Patients With Left Ventricular Assist Device Ertugay, S.
 2014
 33 4S p. S260-S261
2 p.
 artikel
250 Effect of HLA-C and DQ Matching on Pediatric Heart Transplant Graft Survival Butts, R.
 2014
 33 4S p. S151-
1 p.
 artikel
251 Effect of Left Ventricular Assist Device on Ovine Tricuspid Annular 3D Geometry Malinowski, M.
 2014
 33 4S p. S240-
1 p.
 artikel
252 Effect of Match for Ethnicity on Immunologic Events After Heart Transplantation: An Analysis of the UNOS/OPTN Database Carvajal, T.
 2014
 33 4S p. S91-
1 p.
 artikel
253 Effect of Pre-operative Albumin Level on Patient Outcomes after Implantation of Continuous Flow Left Ventricular Assist Device Timek, T.A.
 2014
 33 4S p. S209-S210
2 p.
 artikel
254 Effect on Survival of Double Versus Single Lung Transplantation in Patients with Primary and Secondary Pulmonary Arterial Hypertension Madni, T.
 2014
 33 4S p. S184-S185
2 p.
 artikel
255 Effects of Acute Volume Loading on the Chronically Pressure Overloaded Right Ventricle Boulate, D.
 2014
 33 4S p. S310-
1 p.
 artikel
256 Effects of Organ Donor Factors on Lung Transplant Recipient Outcome at One-Year Follow-Up Auråen, H.
 2014
 33 4S p. S269-S270
2 p.
 artikel
257 Efficacy and Durability of Central Oversewing for Treatment of Aortic Valve Insufficiency in Patients with Continuous Flow Left Ventricular Assist Devices Schechter, M.A.
 2014
 33 4S p. S196-
1 p.
 artikel
258 Efficacy and Safety of Basiliximab as Curative Treatment of Persistent or Complicated Acute Rejection in Cardiac Transplantation Bouregaa, S.
 2014
 33 4S p. S278-
1 p.
 artikel
259 Efficacy and Safety of Paravertebral Block Analgesia Versus General Anaesthesia for Ventricular Assist Device Implantation: A Single-Centre Experience Bejko, J.
 2014
 33 4S p. S205-
1 p.
 artikel
260 Efficacy and Safety of Sustained Release of Vancomycin Through Fibrin Glue Against Local Prosthesis Infection By Methicillin-resistant Staphylococcus aureus Ozaki, S.
 2014
 33 4S p. S181-
1 p.
 artikel
261 Efficacy of Intravenous Tissue Plasminogen Activator (tPA) in Treatment of Device Thrombus in Continuous Flow Left Ventricular Assist Devices with Centrifugal Design Masood, M.F.
 2014
 33 4S p. S132-
1 p.
 artikel
262 Elderly Heart Transplant Recipient Long-Term Survival Is Not Dependent on Donor Age: A Conditional Survival Analysis Ravi, Y.
 2014
 33 4S p. S161-
1 p.
 artikel
263 Elevated Hyaluronan Is Associated with Bronchiolitis Obliterans Syndrome Todd, J.L.
 2014
 33 4S p. S106-S107
2 p.
 artikel
264 Emergency Care for Patients with Continuous Flow Left Ventricular Assist Devices Shah, K.B.
 2014
 33 4S p. S220-S221
2 p.
 artikel
265 Emerging Combination Activity and Resistance Profile for Brincidofovir (CMX001) in CMV Prevention and Treatment Foster, S.
 2014
 33 4S p. S152-
1 p.
 artikel
266 Endobronchial Therapeutics in Lung Transplant Recipients: A Multi-Center Experience Rokadia, H.K.
 2014
 33 4S p. S185-S186
2 p.
 artikel
267 End-organ Dysfunction as a Predictor of Outcomes after Implantation of Continuous Flow Left Ventricular Assist Devices (LVAD) Landis, Z.C.
 2014
 33 4S p. S215-S216
2 p.
 artikel
268 Endothelial Glycocalyx Integrity Is Critical To Organ Function During Human Ex-Vivo Lung Perfusion Chambers, D.C.
 2014
 33 4S p. S17-
1 p.
 artikel
269 Endothelin-1 Levels in Patients With Heart Failure With Normal Ejection Fraction and Pulmonary Venous Hypertension Moza, A.
 2014
 33 4S p. S311-S312
2 p.
 artikel
270 Enhancing National Organ Donations by Prioritizing Registered Donors During Organ Allocation Lavee, J.
 2014
 33 4S p. S46-S47
2 p.
 artikel
271 Epidemiology, Mortality and Risk Factors of Primary and Secondary Graft Failure According with ISHLT Consensus Criteria Vitale, G.
 2014
 33 4S p. S173-
1 p.
 artikel
272 Epidemology and Outcomes Associated With Anemia During Long-Term Continuous-Flow Left Ventricular Assist Device Support Jennings, D.L.
 2014
 33 4S p. S213-S214
2 p.
 artikel
273 Epistaxis in Patients with Left Ventricular Assist Devices - Incidence, Risk Factors, and Implications Bhat, P.
 2014
 33 4S p. S246-
1 p.
 artikel
274 Epithelial Injury and Dysregulated Repair in Small and Large Airways of Lung Transplant Patients is Ameliorated by Azithromycin Kicic, A.
 2014
 33 4S p. S106-
1 p.
 artikel
275 Erratic Tacrolimus Blood Levels are Associated with Bronchiolitis Obliterans Syndrome (BOS) and Death after Lung Transplantation Gallagher, H.M.
 2014
 33 4S p. S68-
1 p.
 artikel
276 Esophageal Motility and Impedance-pH in Lung Transplant Recipients Lien, D.
 2014
 33 4S p. S293-S294
2 p.
 artikel
277 Esophogeal Motility and Impedence pH in Patients Listed for Lung Transplantation Lien, D.
 2014
 33 4S p. S286-
1 p.
 artikel
278 Establishing a Novel Protocol for Heart Bioscaffold Cryopreservation Hemphill, C.
 2014
 33 4S p. S109-
1 p.
 artikel
279 Evaluating Pediatric Heart Re-transplant Candidates: Using a Risk Prediction Model to Estimate Early Mortality after Re-Transplant Siehr, S.L.
 2014
 33 4S p. S122-
1 p.
 artikel
280 Evaluation of GI bleeding in LVAD Patients: A Single Center Review Miracle, K.
 2014
 33 4S p. S301-
1 p.
 artikel
281 Evaluation of Human Lungs from Uncontrolled Donation After Cardiac Death Donors (uDCDDs) with Ex-vivo Lung Perfusion (EVLP) Egan, T.M.
 2014
 33 4S p. S47-
1 p.
 artikel
282 Evaluation of Pump Speed Changes with Exercise in Patients with Continuous Flow Ventricular Assist Devices Lai, J.V.
 2014
 33 4S p. S155-S156
2 p.
 artikel
283 Everolimus and Cyclosporine Equally Improve QoL in De Novo Heart Transplanted Patients: The Results of a Randomized Controlled Trial (SCHEDULE Trial) Relbo, A.
 2014
 33 4S p. S128-
1 p.
 artikel
284 Everolimus Initiation With Calcineurin Inhibitor Withdrawal Reduces Allograft Vasculopathy in De-Novo Heart Transplant Recipients Arora, S.
 2014
 33 4S p. S154-
1 p.
 artikel
285 Evolution of Donor Lung Utilization after Initiation of New Lung Transplant Program Laisaar, T.
 2014
 33 4S p. S262-S263
2 p.
 artikel
286 Evolution of the Association Between Obesity and Survival after Adult Lung Transplantation in the Lung Allocation Score Era Snyder, M.E.
 2014
 33 4S p. S79-
1 p.
 artikel
287 Evolving Experience of Treating Antibody-Mediated Rejection Following Lung Transplantation Otani, S.
 2014
 33 4S p. S191-
1 p.
 artikel
288 Evolving Practice: X Linked Agammaglobulinemia and Lung Transplantation Westall, G.P.
 2014
 33 4S p. S287-S288
2 p.
 artikel
289 Examining Long-Term Outcomes in Heart Transplantation Using Donors With a History of Past and Present Cocaine Use Jayarajan, S.
 2014
 33 4S p. S116-S117
2 p.
 artikel
290 Excellent Long-Term Survival with Extended Ischemic Time in Orthotopic Heart Transplantation Smith, J.W.
 2014
 33 4S p. S117-S118
2 p.
 artikel
291 Exercise Capacity in Continuous Flow Ventricular Assist Devices Patients: Changes Within the First Two Years of Pump Support Moscato, F.
 2014
 33 4S p. S59-
1 p.
 artikel
292 Exercise Capacity in De-Novo Heart Transplant Recipents With Everolimus Vs Conventional CNI Based Immunosuppresion. The Results of a Randomized Trial (SCHEDULE) Gude, E.
 2014
 33 4S p. S134-
1 p.
 artikel
293 Expanded Thymic CD25+FOXP3+ Regulatory T Cells (Tregs) Maintain Stable Function and Phenotype Under Inflammatory Conditions - Potential for Cellular Therapy? Dijke, E.
 2014
 33 4S p. S28-
1 p.
 artikel
294 Expression of S100A4 Protein is T Cell-mediated in a Humanized Model of Obliterative Airway Disorder Guihaire, J.
 2014
 33 4S p. S166-S167
2 p.
 artikel
295 Extended Bridge To Transplant: 4 Years Outcomes With 3rd Generation LVADs in an Era of Restricted Transplantation Butt, T.A.
 2014
 33 4S p. S218-
1 p.
 artikel
296 Extended Preservation of Lungs at Subnormothermia with a Novel Organ Storage Solution “Somah”: Salvage, Reconditioning and Functional Evaluation Louis, A.V.
 2014
 33 4S p. S71-
1 p.
 artikel
297 Extracorporeal Life Support in ‘Awake’ Patients as a Bridge to Lung Transplantation Mohite, P.N.
 2014
 33 4S p. S140-S141
2 p.
 artikel
298 Extracorporeal Membrane Oxygenation as a Bridge to Decision for INTERMACS 1 Patients Moriguchi, J.
 2014
 33 4S p. S250-S251
2 p.
 artikel
299 Extracorporeal Membrane Oxygenation as a Bridge to Recovery, Bridge to Ventricular Assist Device and Bridge to Heart Transplantation: A Retrospective Review of Data From a Single Tertiary Care Institution Balasubramanya, S.
 2014
 33 4S p. S78-
1 p.
 artikel
300 Extracorporeal Membrane Oxygenation as Rescue Therapy in Critically Ill Patients - Is It Worth the Effort? Schäfer, T.
 2014
 33 4S p. S248-
1 p.
 artikel
301 Extracorporeal Membrane Oxygenation (ECMO) Practices for Bridging to Lung Transplantation in North America: A Multi-Center Survey Fadul, R.
 2014
 33 4S p. S246-S247
2 p.
 artikel
302 Extracorporeal Membrane Oxygenation Support in Refractory Cardiogenic Shock: Treatment Strategies and Analysis of Risk Factors Loforte, A.
 2014
 33 4S p. S248-S249
2 p.
 artikel
303 Extracorporeal Membrane Oxygenator Bridge To Ventricular Assist Device Implantation for Patients in Profound Cardiogenic Shock Achieves Stabilization and Improved Results Lo, C.
 2014
 33 4S p. S248-
1 p.
 artikel
304 Extracorporeal Photoimmune Therapy (ECP) with UVADEX in Conjunction with Standard Therapy Compared to Standard Therapy Alone for the Prevention of Rejection in Lung Transplantation Patients Jaksch, P.
 2014
 33 4S p. S291-S292
2 p.
 artikel
305 Extravascular Lung Water Measurement During Ex Vivo Lung Perfusion Linacre, V.
 2014
 33 4S p. S168-
1 p.
 artikel
306 Ex-Vivo Lung Perfusion Does Not Have a Negative Effect on Transplant Rates at Centers without This Technology in a Single Organ Procurement Organization (OPO) Tiwari, J.L.
 2014
 33 4S p. S269-
1 p.
 artikel
307 Ex-Vivo Lung Perfusion for Infected Non-Acceptable Donor Lungs: A Pilot Study Samano, M.N.
 2014
 33 4S p. S290-
1 p.
 artikel
308 Ex Vivo Perfusion Treatment of Infection in Human Donor Lungs Nakajima, D.
 2014
 33 4S p. S28-
1 p.
 artikel
309 Factors Associated With Early Bacterial Infection After Lung Transplantation in Cystic Fibrosis Patients in Two French Centers With Different Antibiotic Prophylaxis Regimen Picard, C.
 2014
 33 4S p. S294-S295
2 p.
 artikel
310 Factors Influencing Waiting Time on the Heart Transplant Waiting List in Australia and New Zealand Ruygrok, P.
 2014
 33 4S p. S262-
1 p.
 artikel
311 Factors Related to Pump Thrombosis at Select Medium to High Volume Centers Klodell, C.T.
 2014
 33 4S p. S131-
1 p.
 artikel
312 Fate of Bronchial Artery Circulation after Lung Transplantation: A Revisit Using Micro CTA Techniques in Rats Noda, K.
 2014
 33 4S p. S258-
1 p.
 artikel
313 Fat Free Mass, Body Mass Index, and Functional Capacity in Patients Awaiting Lung Transplantation Dolan, J.M.
 2014
 33 4S p. S299-
1 p.
 artikel
314 Favorable Outcomes of Left Ventricular Assist Device as Bridge to Simultaneous Heart Kidney Transplantation Murtaza, G.
 2014
 33 4S p. S56-S57
2 p.
 artikel
315 FGF23 and Klotho as Cardiovascular Risk Factors in Heart Transplant Recipients Przybylowski, P.
 2014
 33 4S p. S259-S260
2 p.
 artikel
316 Fibroblast Growth Factor 23 is a Promising Biomarker of Cardiac Hypertrophy Polyakova, V.
 2014
 33 4S p. S273-
1 p.
 artikel
317 Fighting Flu: A Survey of Seasonal Influenza Vaccination Concordance in Cardiothoracic Transplant Patients in Newcastle (UK) Wort, A.
 2014
 33 4S p. S179-
1 p.
 artikel
318 First Experience With the Novel Proteasome Inhibitor Carfilzomib for Antibody Mediated Rejection After Lung Transplantation Ensor, C.R.
 2014
 33 4S p. S114-
1 p.
 artikel
319 First Implantation in Human of a Wireless Miniaturized Intracardiac Pressure Sensor in a Patient with a HeartMate II™ Hubbert, L.
 2014
 33 4S p. S13-
1 p.
 artikel
320 First Lung Transplants Using Controlled and Uncontrolled DCD Lungs Evaluated With OCS-Lung Portable Exvivo Perfusion System Moradiellos, F.
 2014
 33 4S p. S96-
1 p.
 artikel
321 First Mid-Term Results Following Minimally Invasive LVAD Implantation Rojas, S.V.
 2014
 33 4S p. S59-
1 p.
 artikel
322 First Report of the PAS INTERMACs Registry of the HVAD in Commercial Use Maltais, S.
 2014
 33 4S p. S36-S37
2 p.
 artikel
323 Five -Fold Increase in Antibody-Mediated Rejection (AMR) Post-Heart Transplant in Patients Developing Allosensitization During Left Ventricular Assist Device Support (LVAD) Mody, K.P.
 2014
 33 4S p. S100-
1 p.
 artikel
324 Fontan-associated Protein Losing Enteropathy and Heart Transplant: A Pediatric Heart Transplant Study Analysis Schumacher, K.R.
 2014
 33 4S p. S151-S152
2 p.
 artikel
325 Fortuity or Causality: Relation Between Outflow Graft Site of Anastomosis on Aorta and Cerebral Ischemic Events in LVAD Implantation Bejko, J.
 2014
 33 4S p. S205-S206
2 p.
 artikel
326 Frailty in the Lung Transplant Candidate Rozenberg, D.
 2014
 33 4S p. S79-S80
2 p.
 artikel
327 Frailty Is Associated With Increased Time on Ventilator in Patients Undergoing Left Ventricular Assist Device Implantation: A Prospective Study Manghelli, J.
 2014
 33 4S p. S36-
1 p.
 artikel
328 Frailty Is Common in Patients Undergoing Left Ventricular Assist Device Implantation Regardless of Age or Transplant Eligibility: Results from a Prospective Trial Joseph, S.M.
 2014
 33 4S p. S212-
1 p.
 artikel
329 Frofile of Donor Hearts in Brazil Melo, J.L.
 2014
 33 4S p. S265-S266
2 p.
 artikel
330 From Bench To Bedside: Can the Improvements in LVAD Design Mitigate Adverse Events and Increase Survival Rate? Tarzia, V.
 2014
 33 4S p. S155-
1 p.
 artikel
331 Functional Resuscitation of Hearts Preserved in Somah at Subnormothermia: A Comparative Study Lowalekar, S.K.
 2014
 33 4S p. S120-
1 p.
 artikel
332 Functional Status of US Children After Heart Transplantation Peng, D.M.
 2014
 33 4S p. S110-
1 p.
 artikel
333 Gender and Race Association with Tacrolimus (CYP3A5) and Simvastatin (SLOCO1B1) Polymorphisms in an Adult Heart Transplant Population Haglund, N.A.
 2014
 33 4S p. S15-S16
2 p.
 artikel
334 Gender Specific Influences on Effector T-Cell Function and Proliferation: Hormonal Targeting to Modulate Cellular Rejection in Transplantation Luc, J.G.
 2014
 33 4S p. S167-
1 p.
 artikel
335 Gene Expression Profile Score Variability Characteristics: Analysis of 49,836 Tests From 12,177 Heart Transplant Patients Kao, A.
 2014
 33 4S p. S135-
1 p.
 artikel
336 Gene Expression Profiling Test (GEP) Scores and Outcomes of Heart Transplant with Prior Mechanical Circulatory Support: Results from IMAGE and CARGO II Uriel, N.
 2014
 33 4S p. S217-
1 p.
 artikel
337 Genetic Variation in Immunoglobulin G Receptor Affects Survival After Lung Transplantation Ruttens, D.
 2014
 33 4S p. S30-
1 p.
 artikel
338 Getting Ready and Then Keeping Quiet? Exploring Grief With Pre and Post-Transplant Patients Poole, J.M.
 2014
 33 4S p. S222-S223
2 p.
 artikel
339 Global Left Ventricular Relaxation: A Novel Tissue Doppler Index of Acute Rejection in Pediatric Heart Transplantation Hernandez, L.E.
 2014
 33 4S p. S44-
1 p.
 artikel
340 Global Myocardial Viability by Thallium-201 Redistribution Imaging Can Predict Successful Weaning from Short Term Mechanical Support Dionizovik-Dimanovski, M.
 2014
 33 4S p. S203-S204
2 p.
 artikel
341 Halofuginone Inhibition of Th17 Cell Differentiation Attenuates Obliterative Bronchiolitis in Mouse Orthotopic Lung Transplantation Oishi, H.
 2014
 33 4S p. S98-
1 p.
 artikel
342 Halting BOS in Lung Transplant: Is Cyclosporine Conversion the Answer? Stuckey, L.J.
 2014
 33 4S p. S294-
1 p.
 artikel
343 Has the Survival in Heart Transplant Recipients Older > 65years Improved Over the Decades? Ravi, Y.
 2014
 33 4S p. S266-S267
2 p.
 artikel
344 HAVE You Been Fully Evaluated? The Hypertension and Vascular Evaluation Program Detects Nocturnal and Masked Hypertension as Well as Increased Carotid Intima-Media Thickness in Pediatric Heart Transplant Recipients Bober, C.
 2014
 33 4S p. S308-
1 p.
 artikel
345 Heart Failure Classification Rather Than Ejection Fraction May Be a Major Factor in Considering Patients with Hypertrophic Cardiomyopathy for Heart Transplantation Hryniewicz, K.
 2014
 33 4S p. S169-S170
2 p.
 artikel
346 Heart Failure Symptom Clusters and Functional Status Salyer, J.
 2014
 33 4S p. S125-
1 p.
 artikel
347 Heart Failure with Preserved Ejection Fraction Induced Reactive Pulmonary Hypertension Lacks Nitric Oxide Vasoreactivity Similar to Pulmonary Arterial Hypertension Salamon, J.
 2014
 33 4S p. S146-S147
2 p.
 artikel
348 Heart (HT) Versus Heart-Kidney Transplantation (H+K) in Chronic Kidney Disease (CKD) - Should Our Decisions Be Better Informed? ISHLT Registry Analysis DePasquale, E.C.
 2014
 33 4S p. S65-S66
2 p.
 artikel
349 Heartmate II Inflow Cannula Migration Does Not Predict Late-Term Complications Sell, K.A.
 2014
 33 4S p. S200-S201
2 p.
 artikel
350 HeartMate II Pump Exchange in the Continuous Flow Pump Era Is Associated with Increased Mortality Harvey, L.
 2014
 33 4S p. S201-S202
2 p.
 artikel
351 Heart Rate After Heart Transplantation - An Independent Predictor of Long Term Survival. Impact of Beta Blockade on Mortality After Heart Transplantation Ciarka, A.
 2014
 33 4S p. S173-
1 p.
 artikel
352 Heart Recipients With a Lower Response To the 23-Valent Pneumococcal Polysaccharide Vaccine Are at Significant Risk of Bacterial Infection After Transplantation Sarmiento, E.
 2014
 33 4S p. S21-
1 p.
 artikel
353 Hearts Preserved in Somah at Sub-normothermia Demonstrate Rapid Functional Restoration and Are Less Likely To Develop Heart Failure Upon Transplantation Lowalekar, S.K.
 2014
 33 4S p. S176-
1 p.
 artikel
354 Heart Transplantation After Ex-Vivo Perfusion of the Donor Hearts: Does it Affect Inotropic Use and Hospital Stay? Ardehali, A.
 2014
 33 4S p. S117-
1 p.
 artikel
355 Heart Transplantation for Myocarditis: Outcomes and Survival in a National Cohort Jawitz, O.K.
 2014
 33 4S p. S64-S65
2 p.
 artikel
356 Heart Transplantation Outcomes in Hepatitis C Patients: Influence of New Treatment Options on Post-transplantation Survival Quader, M.
 2014
 33 4S p. S157-S158
2 p.
 artikel
357 Heart Transplantation Outcomes in Patients with Continuous Flow Left Ventricular Assist Device Related Complications Quader, M.
 2014
 33 4S p. S99-
1 p.
 artikel
358 Heart Transplantation With Organs Procured After Cardio-Circulatory Death and the Organ Care System. Assessment and Reconditioning of Hearts in a Porcine Model García Sáez, D.
 2014
 33 4S p. S118-S119
2 p.
 artikel
359 Heart Transplant Recipient and Donor Age Mismatching: Should the Older Recipient Be Paired with the Older Donor? Whitson, B.A.
 2014
 33 4S p. S163-
1 p.
 artikel
360 HeartWare Ventricular Assist Device Implantation: Are In-Hospital Outcomes Using a Minimally Invasive Thoracotomy Approach Comparable to Conventional Sternotomy? Haglund, N.
 2014
 33 4S p. S38-
1 p.
 artikel
361 Hemodynamic Compromising Antibody Mediated Rejection (HC-AMR) After Heart Transplantation Aliabadi, A.Z.
 2014
 33 4S p. S175-S176
2 p.
 artikel
362 Hemodynamic Correlates and Prognostic Implication of Vasodilator Response in Reactive Pulmonary Hypertension Due To Left Heart Disease (PHLHD) Lim, S.
 2014
 33 4S p. S276-
1 p.
 artikel
363 Hemodynamic Effects of Partial Right Ventricular Support in the Acute Vs the Chronic Pressure Overloaded Right Ventricle Verbelen, T.
 2014
 33 4S p. S85-S86
2 p.
 artikel
364 Hemodynamics of Pulmonary Hypertension in the Setting of Hereditary Hemorrhagic Telangiectasia Lyle, M.A.
 2014
 33 4S p. S310-S311
2 p.
 artikel
365 Hepatitis B Vaccination Confers an Increased Rate of Transplant for Patients on the Heart Transplant Waiting List Stimpson, E.
 2014
 33 4S p. S268-
1 p.
 artikel
366 High Emergency Lung Transplantation: The Experience of a French Centre Beaumont, L.
 2014
 33 4S p. S270-
1 p.
 artikel
367 Higher Quality of Caregiver Support Is Associated with Post-Transplant Adherence at 6 Months Rowan, J.M.
 2014
 33 4S p. S34-
1 p.
 artikel
368 Higher Serum Galectin-3 Levels Correlate to Lower Cerebral Tissue Oxygenation in Heart Failure Patients Rifai, L.
 2014
 33 4S p. S274-S275
2 p.
 artikel
369 High Expression of Plasmocytoid Dendritic Cells in Peripheral Blood Lower the Risk of Acute Cellular Rejection in Heart Transplant Recipients Barten, M.J.
 2014
 33 4S p. S281-S282
2 p.
 artikel
370 High Molecular Weight Serum Adiponectin Levels in Advanced Heart Failure Patients Before and After Continuous Flow Left Ventricular Assistance Device Denadai Benatti, R.
 2014
 33 4S p. S232-
1 p.
 artikel
371 High Prevalence of Warfarin Genotype Polymorphisms in Patients with Mechanical Circulatory Support Awad, M.
 2014
 33 4S p. S116-
1 p.
 artikel
372 Histologic Findings in Allograft Lung Biopsies: Correlation With Serologic Alloimmunity Collins, J.A.
 2014
 33 4S p. S112-
1 p.
 artikel
373 HLA Mismatches Is an Independent Risk Factor for Worse Patient Survival among Lung Transplant Recipients in the United States Askar, M.
 2014
 33 4S p. S188-S189
2 p.
 artikel
374 Home Milrinone Therapy in Pediatric Advanced Heart Failure Murray, L.
 2014
 33 4S p. S304-
1 p.
 artikel
375 Hospital Charges for Pediatric Heart Failure Related Hospitalizations Admissions in the United States from 2000 to 2009 Nandi, D.
 2014
 33 4S p. S307-S308
2 p.
 artikel
376 Hospital Readmissions After Left Ventricular Assist Device Implantation Are Associated With Poor Outcomes: A Single Center Experience Ashrith, G.
 2014
 33 4S p. S198-
1 p.
 artikel
377 Hospital Readmission with LVAD Destination Therapy Klotz, S.
 2014
 33 4S p. S198-S199
2 p.
 artikel
378 How Does Donor Specific Antibody Relate to Biopsy-diagnosed Antibody-mediated Rejection after Pediatric Heart Transplantation? Ware, A.
 2014
 33 4S p. S123-S124
2 p.
 artikel
379 How Donor Graft Lungs Behave in a Recipient Thorax After Living-Donor Lobar Lung Transplantation: 2-Year Follow-up Chen, F.
 2014
 33 4S p. S182-
1 p.
 artikel
380 How Do Readmissions Impact Survival Among Patients with Continuous-Flow Left Ventricular Assist Devices? Findings from INTERMACS Vivo, R.P.
 2014
 33 4S p. S87-
1 p.
 artikel
381 Human iPS-cell-derived Engineered Heart Tissue for Cardiac Repair Pecha, S.
 2014
 33 4S p. S108-S109
2 p.
 artikel
382 Humoral Allo and Auto Immunity in Human Lung Transplant Recipients Gjorgjimajkoska, O.
 2014
 33 4S p. S81-
1 p.
 artikel
383 Humoral Immunity Profiles to Identify CMV-seropositive Heart Recipients at Risk of CMV Disease: A Prospective Multicenter Study Sarmiento, E.
 2014
 33 4S p. S20-
1 p.
 artikel
384 Hypercapnic Ventilatory Response Is Decreased in Long-Term Bilateral Lung Transplant Recipients Weidmann, M.J.
 2014
 33 4S p. S187-
1 p.
 artikel
385 Identification of a High-Risk Group for Development of BOS Using Latent Class Analysis Shah, R.
 2014
 33 4S p. S107-S108
2 p.
 artikel
386 Identification of Independent Risk Factors for De Novo DSA Development Through Prospective Monitoring Islam, A.K.
 2014
 33 4S p. S159-
1 p.
 artikel
387 Identification of MicroRNA 628-5p as a Novel Biomarker for Cardiac Allograft Vasculopathy (CAV) Neumann, A.
 2014
 33 4S p. S85-
1 p.
 artikel
388 Identifying Optimal Treatment Regimens for Lung and Heart Transplant Patients (LTx, HTx pts) Infected With Extreme-Drug Resistant (XDR) Gram-Negative Bacteria Clancy, C.
 2014
 33 4S p. S153-
1 p.
 artikel
389 If I Had a Million Lungs: Impact of Uncontrolled Donation After Cardiac Death Donors (uDCDDs) on the Number of Potential Lung Donors in the U.S. Egan, T.M.
 2014
 33 4S p. S47-
1 p.
 artikel
390 IL-6 Blockage by Anti-Interleukin-6 Receptor Antibody Suppresses Plasma Cells during Development of Alloantibody Responses WU, G.
 2014
 33 4S p. S81-S82
2 p.
 artikel
391 Image Guided Evaluation of Cellular Retention and Survival After Intramyocardial Transcatheter Based Mesenchymal Stem Cell Transplantation Into the Infarcted Pig Heart Emmert, M.Y.
 2014
 33 4S p. S256-
1 p.
 artikel
392 Immunoadsorption: A Treatment Alternative for Older Patients with β1-Autoantibody Positive Dilated Cardiomyopathy Who Are at Higher Risk for Transplantation Dandel, M.
 2014
 33 4S p. S78-S79
2 p.
 artikel
393 Impact of Cardiac Arrest Resuscitated Donors on Heart Recipients Outcome Galeone, A.
 2014
 33 4S p. S103-S104
2 p.
 artikel
394 Impact of Demographics on Airway Obstruction on Spirometry Among Patients With Lung Transplantation Banga, A.
 2014
 33 4S p. S298-
1 p.
 artikel
395 Impact of Device Design and Patient Management on the Incidence of Neurologic Events after HVAD Left Ventricular Assist Device Teuteberg, J.J.
 2014
 33 4S p. S10-
1 p.
 artikel
396 Impact of Donor and Recipient Socio-economic Status (SES) on Outcomes in Adult Heart Transplantation: Does It Really Matter? Nixon, J.L.
 2014
 33 4S p. S126-S127
2 p.
 artikel
397 Impact of Early Major Adverse Events on Quality of Life After Mechanical Circulatory Support Holtz, J.
 2014
 33 4S p. S308-S309
2 p.
 artikel
398 Impact of Extended Cold Ischemic Times on the Outcome of Clinical Lung Transplantation Using Ex Vivo Lung Perfusion (EVLP) Krueger, T.
 2014
 33 4S p. S94-
1 p.
 artikel
399 Impact of Initial Reperfusion Temperature on the Functional Recovery of DCD Hearts White, C.W.
 2014
 33 4S p. S109-
1 p.
 artikel
400 Impact of Left Ventricular Assist Device Support on Bridging to Transplantation in Adults with Restrictive Cardiomyopathy Healy, A.H.
 2014
 33 4S p. S85-
1 p.
 artikel
401 Impact of Mechanical Support on Quality of Life Measures Over Time - Is There a Differential Response Based Upon Indication? Teuteberg, J.J.
 2014
 33 4S p. S226-S227
2 p.
 artikel
402 Impact of Minimally Invasive Lung Transplantation on Postoperative Renal Outcomes Romano, R.
 2014
 33 4S p. S295-S296
2 p.
 artikel
403 Impact of Preimplantation Tricuspid Regurgitation on Long Term Outcome in Patients Undergoing LVAD Implantation in the Era of Rotary Blood Pumps Ghodsizad, A.
 2014
 33 4S p. S240-S241
2 p.
 artikel
404 Impact of Preoperative Atrial Fibrillation on Outcomes Following Continuous Flow LVAD Implantation Stern, D.
 2014
 33 4S p. S193-
1 p.
 artikel
405 Impact of Pre-Sensitization and Positive Virtual Cross-Match on Outcomes in Pediatric Heart Transplantation Zuckerman, W.A.
 2014
 33 4S p. S304-S305
2 p.
 artikel
406 Impact of Pre-Transplant Pleurodesis in the Outcome After Lung Transplantation for Lymphagioleiomyomatosis Sakamoto, J.
 2014
 33 4S p. S289-S290
2 p.
 artikel
407 Impact of Pre-Transplant Staphylococcus Aureus Colonization on Post-Transplant S. aureus Infection Among Cystic Fibrosis Lung Transplant Recipients St-Pierre, J.
 2014
 33 4S p. S138-
1 p.
 artikel
408 Impact of vWF Activity in the Long-term Management of Centrifugal Type Continuous-flow LVAD Patients Ichihara, Y.
 2014
 33 4S p. S87-
1 p.
 artikel
409 Impacts of Donor Smoking History and Age on Lung Transplant Survival Ren, D.
 2014
 33 4S p. S271-
1 p.
 artikel
410 Impella 5.0 through an Axillary Access Is a Promising Approach to Improve Outcomes in Decompensated Heart Failure Patients to Receive Long-term Mechanical Circulatory Assistance Doersch, K.M.
 2014
 33 4S p. S61-
1 p.
 artikel
411 Implementation and Medium-Term Outcomes of a Center-Specific High-Urgency Anti-HLA Antibody Policy Stoddart, A.
 2014
 33 4S p. S291-
1 p.
 artikel
412 Importance of Genetic Evaluation in Pediatric Restrictive Cardiomyopathy Thrush, P.T.
 2014
 33 4S p. S306-
1 p.
 artikel
413 Improvement in Acquired Von Willebrand Syndrome with Aortic Valve Opening in Patients with Centrifugal Continuous Flow Left Ventricular Assist Devices Muthiah, K.
 2014
 33 4S p. S22-S23
2 p.
 artikel
414 Improvement in Left and Right Ventricular Function Measured by 3-D Echocardiography Following Centrifugal Continuous Flow Left Ventricular Assist Device Support Muthiah, K.
 2014
 33 4S p. S214-S215
2 p.
 artikel
415 Improvement of Endothelial Function After Stem Cells Transplantation in Patients With Heart Failure Sebestjen, M.
 2014
 33 4S p. S274-
1 p.
 artikel
416 Improving Prothrombin Time International Normalized Ratio (INR) Control in Left Ventricular Assist Device (LVAD) Patients with Computerized Decision Support Nixon, J.L.
 2014
 33 4S p. S241-
1 p.
 artikel
417 Improving the Heart Transplant Decision Making Process: 10-year Experience Using the Heart Transplant Candidate Selection Form Young, Q.
 2014
 33 4S p. S223-
1 p.
 artikel
418 Incidence and Importance of Donor-Specific HLA Antibody in Heart Transplant Recipients Zhang, Q.
 2014
 33 4S p. S24-S25
2 p.
 artikel
419 Incidence and Predictors of Myocardial Recovery on Heartmate II Left Ventricular Assist Device Support: Results From the United Network Organ Sharing Database Topkara, V.K.
 2014
 33 4S p. S88-
1 p.
 artikel
420 Incidence of Hemolysis in Patients With Cardiogenic Shock Treated With Impella Percutaneous Left Ventricular Assist Device Hernandez, G.A.
 2014
 33 4S p. S251-S252
2 p.
 artikel
421 Increased BMI Is Associated with Left Ventricular Assist Device-related Infectious Complications Raymer, D.S.
 2014
 33 4S p. S197-
1 p.
 artikel
422 Increased Plasma Levels of Graft-Derived Cell-Free DNA Correlate with Rejection in Heart Transplant Recipients Kobashigawa, J.
 2014
 33 4S p. S14-
1 p.
 artikel
423 Increased Sensitization To HLA and To Cardiac Self-Antigens (Myosin and Vimentin) in Patients Waiting for Cardiac Transplantation With Left Ventricular Assisting Device (LVAD) Banan, B.
 2014
 33 4S p. S25-
1 p.
 artikel
424 Increasing Pump Speed During Exercise Improves Peak Oxygen Consumption in Heart Failure Patients Supported With Continuous-Flow Left Ventricular Assist Devices - A Double-Blind Randomized Study Jung, M.H.
 2014
 33 4S p. S13-
1 p.
 artikel
425 Increasing Use of Mechanical Circulatory Support as a Bridge to Cardiac Retransplantation Clerkin, K.J.
 2014
 33 4S p. S100-S101
2 p.
 artikel
426 Independent Prognostic Value of Peak Oxygen Consumption in ICD and Non-ICD Patients Alba, A.C.
 2014
 33 4S p. S275-
1 p.
 artikel
427 Induction Therapy in African American Infant Heart Transplants: Is There a Benefit? Coleman, B.
 2014
 33 4S p. S43-
1 p.
 artikel
428 Induction With Anti-Thymocyte Globulin After Heart Transplantation Is Associated with Better Long-term Survival Compared to Basiliximab Lund, L.
 2014
 33 4S p. S145-
1 p.
 artikel
429 Infection Incidence and Types of Pathogens After Heart Transplantation: Institutional Experience Sargin, M.
 2014
 33 4S p. S264-
1 p.
 artikel
430 Infectious Complications Following Treatment of Antibody Mediated Rejection in Cardiothoracic Transplant Recipients Moten, M.A.
 2014
 33 4S p. S181-
1 p.
 artikel
431 Influence of Aortic Valve Opening in Patients With Aortic Insufficiency After LVAD Implantation da Rocha e Silva, J.G.
 2014
 33 4S p. S194-S195
2 p.
 artikel
432 Influence of Intraoperative Hemodynamic Factors on the Development of Acute Kidney Injury in Lung Transplantation Romano, R.
 2014
 33 4S p. S192-
1 p.
 artikel
433 Influence of Junctional-Adhesion-Molecules on Transendothelial Migration Under Hypothermic Conditions: What About the Rewarming During Reperfusion? Bogert, N.V.
 2014
 33 4S p. S281-
1 p.
 artikel
434 Influence of MELD (Model of End-Stage Liver Disease)_XI (eXcluding INR) on Pediatric Post-Heart Transplant (HT) Outcomes DePasquale, E.C.
 2014
 33 4S p. S226-
1 p.
 artikel
435 Influence of MELD (Model of End-Stage Liver Disease)_XI (eXcluding INR) on Post-Heart Transplant (HT) Outcomes DePasquale, E.C.
 2014
 33 4S p. S156-S157
2 p.
 artikel
436 Influence of Mitral Regurgitation at Time of Implantation on Outcome in Patients With Ventricular Assist Devices Bernhardt, A.M.
 2014
 33 4S p. S203-
1 p.
 artikel
437 Influence of Oxidative and Anaplerotic Subtrates on Myocardial Metabolism During Hypothermic Machine Perfusion Brant, S.M.
 2014
 33 4S p. S259-
1 p.
 artikel
438 Influence of Varying Definitions of Primary Graft Dysfunction After Heart Transplantation on Incidence and Risk Factors Letzen, B.S.
 2014
 33 4S p. S104-S105
2 p.
 artikel
439 Infusion of Nesiritide after Implantation of the Total Artificial Heart Is Associated with Decreased Need for Kidney Transplantation Shah, K.B.
 2014
 33 4S p. S61-
1 p.
 artikel
440 Inhaled Milrinone Plasma Level Implications in Patients with RV Dysfunction Receiving Heartmate II LVAD Dumitru, I.
 2014
 33 4S p. S77-
1 p.
 artikel
441 Initial Data from a Prospective Observational Study of Hypogammaglobulinemia After Lung Transplantation Traister, R.S.
 2014
 33 4S p. S298-S299
2 p.
 artikel
442 Initial Experience With the Organ Care System in High Risk Donor/Recipient Combination Orthotopic Heart Transplantation (OCTx) García Sáez, D.
 2014
 33 4S p. S119-
1 p.
 artikel
443 Initial Post Approval Performance of the Heartware LVAD as Bridge to Transplantation: An Analysis of the UNOS Database Uriel, N.
 2014
 33 4S p. S74-
1 p.
 artikel
444 Interaction of Pulse Perception, Blood Pressure Measurements (By Doppler and Standard Cuff Techniques) and Visual Assessment of Aortic Valve Opening in Continuous Flow LVAD Patients in the Outpatient Setting Bhimaraj, A.
 2014
 33 4S p. S13-S14
2 p.
 artikel
445 Interstitial Fibrosis of the Lungs and the Heart in the Goat Following Prolonged VA-ECMO Mizuno, T.
 2014
 33 4S p. S62-S63
2 p.
 artikel
446 Intra-aortic Balloon Counterpulsation as a Bridge to Left Ventricular Assist Device Implantation in Patients with End-stage Heart Failure and Cardiogenic Shock Gdowski, M.
 2014
 33 4S p. S253-
1 p.
 artikel
447 Intracranial Hemorrhage Is Associated with a Higher Doppler Blood Pressure during Continuous Flow Left Ventricular Assist Device Support Saeed, O.
 2014
 33 4S p. S24-
1 p.
 artikel
448 Intraplatelet Reactive Oxygen Species, Mitochondrial Damage and Platelet Apoptosis Augment Non-Surgical Bleeding in Heart Failure Patients Supported By Continuous-Flow Left Ventricular Assist Device (CF-LVADs) Mondal, N.K.
 2014
 33 4S p. S130-
1 p.
 artikel
449 Intravenous Immunoglobulin and Plasmapheresis in Prevention of Antibody Mediated Rejection in Sensitized Recipients in Cardiac Allograft. “Before - After” Treatment Study Varnous, S.
 2014
 33 4S p. S145-S146
2 p.
 artikel
450 Invasive Fungal Infections After Heart Transplantation: A Single Center Experience Echenique, I.
 2014
 33 4S p. S137-
1 p.
 artikel
451 In Vivo Evaluation of the Cleveland Clinic Continuous-Flow Total Artificial Heart in Calves Karimov, J.H.
 2014
 33 4S p. S165-S166
2 p.
 artikel
452 In Vivo Testing of a New Permanent Atrial Connector for Cardiac Assist Devices Klotz, S.
 2014
 33 4S p. S206-S207
2 p.
 artikel
453 Is a Priori Staging of Bilateral Lung Transplant the Optimal Surgical Approach for High-risk Patients With Interstitial Lung Disease? Hartwig, M.G.
 2014
 33 4S p. S30-S31
2 p.
 artikel
454 Is Bad Donor in Bad Recipient Leading To Bad Outcomes? Potential Utility of Scores To Achieve Optimal Donor-Recipient Match Amabile, A.
 2014
 33 4S p. S162-S163
2 p.
 artikel
455 Is Doppler Echocardiography Useful for Estimating Ventricular Filling Pressures in Pediatric Heart Transplant Recipients? Lunze, F.I.
 2014
 33 4S p. S304-
1 p.
 artikel
456 Is MFI Value a Solid Ground to Listing Unacceptable HLA Antigens Nikaein, A.
 2014
 33 4S p. S124-S125
2 p.
 artikel
457 Isolated RVAD Implantation - First Results from the EUROMACS Registry Bernhardt, A.M.
 2014
 33 4S p. S238-
1 p.
 artikel
458 Isolated Transfer of Human Platelets Results in Formation of Transplant Arteriosclerosis in a RAG2-/-γ-chain-/- Mouse Aortic Xenograft Model Heim, C.
 2014
 33 4S p. S168-
1 p.
 artikel
459 Is Pre-Existing Liver Cirrhosis and Fibrosis a Contraindication to Heart Transplantation? Sasevich, M.J.
 2014
 33 4S p. S157-
1 p.
 artikel
460 Is Routine Screening for Community-Acquired Respiratory Virus Infections in Lung Transplant Recipients Worthwhile? Greer, M.
 2014
 33 4S p. S192-
1 p.
 artikel
461 Is There a Need for Patient Specific Informed Consent in Heart Transplantation? Yechoor, N.
 2014
 33 4S p. S273-S274
2 p.
 artikel
462 Large Perioperative Red Blood Cell Transfusion Requirements Are Associated with Increased Long Term Mortality After LVAD Implantation Holley, C.T.
 2014
 33 4S p. S245-S246
2 p.
 artikel
463 Late Antibody-Mediated Rejection Due To De-Novo Donor-Specific Anti-HLA Antibodies in Heart Transplant Recipients: A Cohort of 20 Consecutive Patients Coutance, G.
 2014
 33 4S p. S178-
1 p.
 artikel
464 Late Cytomegalovirus (CMV) Infections in Heart Transplantation (HT) Echenique, I.A.
 2014
 33 4S p. S20-
1 p.
 artikel
465 Left Ventricular Internal Diastolic Diameter as a Predictor of Outcomes in Ischemic Cardiomyopathy Shatzkes, J.
 2014
 33 4S p. S274-
1 p.
 artikel
466 Left Ventricular (LV) Response to Unloading by Continuous-flow Left Ventricular Assist Devices (LVAD): Axial Vs. Centrifugal? Rauf, A.
 2014
 33 4S p. S155-
1 p.
 artikel
467 Left Ventricular Remodeling Following LVAD: Does Pulsatility Matter? Bennett, M.K.
 2014
 33 4S p. S155-
1 p.
 artikel
468 Left Ventricular vs. Bi-Ventricular Assist Device Implantation: Improvement of Preoperative Decision Making by Assessing Right Ventricular Adaptation to Loading Conditions Dandel, M.
 2014
 33 4S p. S40-S41
2 p.
 artikel
469 Length of the Agonal Phase in Donors After Cardiac Death Influences Donor Lung Function After Reperfusion in a Rat Model Hijiya, K.
 2014
 33 4S p. S95-
1 p.
 artikel
470 Level and Kinetics of Plasma Torque Teno Virus DNA After Lung Transplantation as a Marker To Guide Immunosuppressive Therapy Görzer, I.
 2014
 33 4S p. S69-
1 p.
 artikel
471 Ligation of Transgenic MHC Class I Molecule Expressed Only in the Lungs By Its Specific Antibodies Induces Epithelial Injury, Autoimmunity and Obliterative Airway Disease (OAD): A Novel Transgenic Mouse Model of OAD Sarma, N.J.
 2014
 33 4S p. S97-
1 p.
 artikel
472 Limitations of Right Heart Catheterization in the Diagnosis and Risk Stratification of Patients with Pulmonary Hypertension: Insights from the CHAMPION Trial Raina, A.
 2014
 33 4S p. S92-
1 p.
 artikel
473 Limited Efficacy of Milrinone as a Bridge to Cardiac Transplantation in the Current Era Kumar, A.
 2014
 33 4S p. S55-S56
2 p.
 artikel
474 Localization of microRNAs in Cardiac Allograft Vasculopathy With In Situ Hybridization; a Role in Immune Regulation and/or Fibrosis? Huibers, M.M.
 2014
 33 4S p. S315-
1 p.
 artikel
475 Local Production of Donor Specific Antibodies (DSA) By Intrapulmonary De Novo Lymphoid Tissue Associated With Allograft Airway Rejection Motoyama, H.
 2014
 33 4S p. S167-
1 p.
 artikel
476 Longer Versus a Shorter Duration Exercise Rehabilitation Program Following Lung Transplant: A Randomised Controlled Trial Fuller, L.M.
 2014
 33 4S p. S32-
1 p.
 artikel
477 Long Term Analysis of RV Function in Patients After Continuous Flow Heartware® LVAD Implantation Without the Need for Peri-Operative Mechanical RV Support - Honeymoon Period or Sustainable Success? Bhagra, C.J.
 2014
 33 4S p. S73-S74
2 p.
 artikel
478 Long Term Clinical Outcome of Pulmonary Re-Transplantation for Chronic Lung Allograft Problems Slama, A.
 2014
 33 4S p. S186-
1 p.
 artikel
479 Long-Term Mechanical Circulatory Support With EVAHEART Left Ventricular Assist Device Nishinaka, T.
 2014
 33 4S p. S205-
1 p.
 artikel
480 Long-term Outcome in Acute Vasodilator Responsive Connective Tissue Disease-Associated Pulmonary Arterial Hypertension Brittain, E.
 2014
 33 4S p. S54-
1 p.
 artikel
481 Long-Term Outcome of Cardiac Transplant After Continuous-Flow Left Ventricular Assist Device Support Takeda, K.
 2014
 33 4S p. S213-
1 p.
 artikel
482 Long-term Outcome of Sirolimus (SRL) Based Immunosuppression (IS) in Heart Transplant Patients Wallner, S.
 2014
 33 4S p. S134-S135
2 p.
 artikel
483 Long-Term Outcomes of Left Ventricular Asisst Device Therapy in Scandinavia Lund, L.H.
 2014
 33 4S p. S216-
1 p.
 artikel
484 Long Term Partial Right Ventricular Support Induces Reverse Remodelling in the Chronic Pressure Overloaded Right Ventricle Verbelen, T.
 2014
 33 4S p. S148-
1 p.
 artikel
485 Long-Term Sildenafil Therapy Improves Right Ventricular Function in Heart Transplant Recipients With Pulmonary Hypertension Vrtovec, B.
 2014
 33 4S p. S278-S279
2 p.
 artikel
486 Long-Term Successful Outcomes From Kidney Transplantation Following Lung/Heart-Lung Transplantation Otani, S.
 2014
 33 4S p. S191-S192
2 p.
 artikel
487 Long-Term Therapy with Everolimus: Promising Results at Three Years of the CERTIC Registry Potena, L.
 2014
 33 4S p. S146-
1 p.
 artikel
488 Low Body Mass Index Is Associated with Increased Waitlist Mortality Among Children Listed for Heart Transplantation Davies, R.R.
 2014
 33 4S p. S120-S121
2 p.
 artikel
489 Low Cardiac Output Stimulates Vasopressin Release in Patients with Stage D Heart Failure - Its Relevance to Poor Prognosis and Reversal by Surgical Treatment Imamura, T.
 2014
 33 4S p. S51-
1 p.
 artikel
490 Low-Density Lipoprotein, High-Density Lipoprotein and Triglyceride Levels all Increase During Continuous-Flow Left Ventricular Assist Device Support Vest, A.R.
 2014
 33 4S p. S61-S62
2 p.
 artikel
491 Low Dose Prothrombin Complex Concentrate in Addition to Vitamin K for Warfarin Reversal Prior to Heart Transplantation Fink, J.
 2014
 33 4S p. S65-
1 p.
 artikel
492 Low IgM Anti-Polysaccharide Antibody Response and Severe Infection in a Cohort of Lung Recipients Sarmiento, E.
 2014
 33 4S p. S153-
1 p.
 artikel
493 Lung Allocation Score Criteria Adjustment and Impacts on Transplantation: A Retrospective Study Carroll, N.D.
 2014
 33 4S p. S271-S272
2 p.
 artikel
494 Lung Retransplantation for Early Graft Failure: Trends and Results in 112 Patients Over a 24-Year Period Kilic, A.
 2014
 33 4S p. S288-
1 p.
 artikel
495 Lung Transplantation for Silicosis, Report of 16 Patients Rosengarten, D.
 2014
 33 4S p. S261-S262
2 p.
 artikel
496 Lung Transplantation in Recipients >70 Years Old: A Single Center Experience Morrell, M.R.
 2014
 33 4S p. S137-
1 p.
 artikel
497 Lung Transplantation in Russian Federation Golovinskiy, S.V.
 2014
 33 4S p. S263-S264
2 p.
 artikel
498 Lung Transplantation in Scleroderma? DePasquale, E.C.
 2014
 33 4S p. S28-S29
2 p.
 artikel
499 Lung Transplantation Using Allografts From Donation After Cardiac Death Donors Costa, J.
 2014
 33 4S p. S188-
1 p.
 artikel
500 Lung Transplant Body Composition Singer, J.P.
 2014
 33 4S p. S79-
1 p.
 artikel
501 Lung Transplant for COPD in the Elderly: It Is Still Indicated? Brown, C.
 2014
 33 4S p. S80-S81
2 p.
 artikel
502 Lung Transplant Waitlist Mortality: Height as a Predictor of Poor Outcomes Keeshan, B.C.
 2014
 33 4S p. S95-S96
2 p.
 artikel
503 LVAD Exchange for Thrombosis Is Associated with Higher Recurrent Rates of Hemolysis, Thrombosis, and Death Andruska, A.M.
 2014
 33 4S p. S131-S132
2 p.
 artikel
504 Macrophages Infiltration Is Associated with Maladaptive Remodeling of the Right Ventricle in an Experimental Model of Pulmonary Hypertension Guihaire, J.
 2014
 33 4S p. S228-
1 p.
 artikel
505 Maintained Cardiac Reserve in Heart Transplant Patients During Early Calcineurin Inhibitor Avoidance: A Substudy of a Randomised Controlled Trial (SCHEDULE Trial) Bartfay, S.
 2014
 33 4S p. S173-S174
2 p.
 artikel
506 Management of Airway Stenoses With Biodegradable Stents After Lung Transplantation. Single Institution Experience Gelvez-Zapata, S.
 2014
 33 4S p. S293-
1 p.
 artikel
507 Marginal Donors: Improvement in Quality of Hearts Transplanted and Mid-Term Survival By Echo-Stress Evaluation Bernazzali, S.
 2014
 33 4S p. S162-
1 p.
 artikel
508 Markedly Reduced Driveline Infection Rates in CF Pumps (HMII) - A Long-term Follow Up Nair, N.
 2014
 33 4S p. S181-
1 p.
 artikel
509 Markers of Lower Pump Flow Are Risk Factors for Pump Thrombosis with the Heartmate II Left Ventricular Assist Device Raina, A.
 2014
 33 4S p. S242-
1 p.
 artikel
510 Mechanical Circulatory Support for Failing Systemic Right Ventricle Using Left Ventricular Assist Device - An Option To Decide and Bridge? Peng, E.
 2014
 33 4S p. S58-S59
2 p.
 artikel
511 Mechanical Circulatory Support for Primary Graft Dysfunction Following Heart Transplantation: Risk Factors and Clinical Outcome Ali, A.A.
 2014
 33 4S p. S279-
1 p.
 artikel
512 Mechanical Circulatory Support Improves Diabetic Control in Patients With Advanced Heart Failure Sundararajan, S.K.
 2014
 33 4S p. S87-S88
2 p.
 artikel
513 Mechanical Ventilation of ECMO Patients Is Associated with Decreased Post-Transplant Survival Bittle, G.J.
 2014
 33 4S p. S286-
1 p.
 artikel
514 Mediastinal Re-Entry in Patients Undergoing Ventricular Assist Device Explantation Prior To Heart Transplantation: Role of Peripheral Cannulation for Cardiopulmonary Bypass Ali, A.A.
 2014
 33 4S p. S285-
1 p.
 artikel
515 Medical Gas (Carbon Monoxide, Hydrogen Sulfide) Therapy Prolongs Survival of the Fully MHC-Disparate Lung Graft From Brain-Dead Donors in Miniature Swine Sahara, H.
 2014
 33 4S p. S49-S50
2 p.
 artikel
516 Metabolic Profiling of Perfusate from Clinical Ex Vivo Lung Perfusion Yields Potential Biomarkers of Early Lung Transplant Outcomes Hsin, M.K.
 2014
 33 4S p. S96-S97
2 p.
 artikel
517 Microbiome Profiling by Whole Genome Sequencing During Acute and Chronic Lung Transplant Rejection Keller, B.C.
 2014
 33 4S p. S183-
1 p.
 artikel
518 MicroRNA-1202 Is a Candidate Biomarker To Assist Selection of Patients for Therapy With a Left Ventricular Assist Device Morley-Smith, A.C.
 2014
 33 4S p. S235-S236
2 p.
 artikel
519 Mid and Late Outcomes Support Use of Contemporary Continuous Flow Left Ventricular Assist Devices in the Elderly Singh, S.K.
 2014
 33 4S p. S210-
1 p.
 artikel
520 Mineralocorticoid Receptor Antagonists Enhance Cardiac Function during Continuous Flow Left Ventricular Assist Device Support Saeed, O.
 2014
 33 4S p. S203-
1 p.
 artikel
521 Minimal Adverse Events in HeartMate II Patients with No Antiplatelet Therapy: Preliminary Results from the European TRACE Study Netuka, I.
 2014
 33 4S p. S11-
1 p.
 artikel
522 miRNAs as Biomakers of Rejection in Heart Transplantation Tible, M.
 2014
 33 4S p. S113-S114
2 p.
 artikel
523 Mixed Acute Cellular Rejection and Antibody Mediated Rejection in Heart Transplantation: A Retrospective Study in a Single Transplant Center Fedrigo, M.
 2014
 33 4S p. S113-
1 p.
 artikel
524 Mixed Rejection Is a Low Frequency Event and Not Just Cellular Rejection and C4d Deposition in the Cardiac Allograft Tan, C.D.
 2014
 33 4S p. S113-
1 p.
 artikel
525 Modulation of Immune-Mediators From Donor Lungs Using the Organ Care System® - A Potential Mechanism for Improved Outcome Wiegmann, B.
 2014
 33 4S p. S17-
1 p.
 artikel
526 Mortality After Readmission Among Heart Failure Patients Benuzillo, J.G.
 2014
 33 4S p. S272-
1 p.
 artikel
527 Mortality Differences Between Men and Women Following the Use of Extracorporeal Membrane Oxygenation (ECMO) after Myocardial Infarction Zhang, R.L.
 2014
 33 4S p. S247-
1 p.
 artikel
528 mTOR Inhibitors in Pediatric Heart Transplantation: Do the Potential Benefits Outweigh the Risks, Clues from the ISHLT Registry Castleberry, C.
 2014
 33 4S p. S43-S44
2 p.
 artikel
529 Multi-Centre Experience of Donor Choice Consent Forms in the United Kingdom Morley, K.E.
 2014
 33 4S p. S300-
1 p.
 artikel
530 Muscularization of Pulmonary Arteries Is Reduced in Female Athymic Rats Exposed to Vascular Endothelial Growth Factor Receptor (VEGF-R) Blockade Guihaire, J.
 2014
 33 4S p. S54-S55
2 p.
 artikel
531 Mycophenolic Acid Area Under the Curve But Not Trough Level or Dose Is Associated With Rejection in Adult Heart Transplant Patients in the First Year Post-Transplantation Woillard, J.
 2014
 33 4S p. S280-S281
2 p.
 artikel
532 Myeloperoxidase is Critically Linked to the Development of Diastolic Heart Failure Following Pressure Overload Deuschl, F.G.
 2014
 33 4S p. S164-
1 p.
 artikel
533 Myocardial Microvascular Density Increases After Chronic Continuous Flow Left Ventricular Assist Device (CF-LVAD) Support Yuzefpolskaya, M.
 2014
 33 4S p. S236-S237
2 p.
 artikel
534 Myocardial Regeneration and Recovery with Extracellular Matrix and LVAD Support Slaughter, M.S.
 2014
 33 4S p. S142-S143
2 p.
 artikel
535 Myocardial Scar Burden and Response to Stem Cell Therapyin Heart Failure Patients Zemljič, G.
 2014
 33 4S p. S275-
1 p.
 artikel
536 Nasal Mucosal Changes during Continuous Flow (CF)- LVAD Support Gunda, S.
 2014
 33 4S p. S243-S244
2 p.
 artikel
537 Need for Renal Replacement Therapy after Cardiac Transplantation in Patients with AL Amyloidosis Is Associated with Poor Survival Niehaus, E.D.
 2014
 33 4S p. S91-S92
2 p.
 artikel
538 Neurologic Complications After Implantation of Total Artificial Heart Tchoukina, I.
 2014
 33 4S p. S196-
1 p.
 artikel
539 Neutrophilic Enzymes in Human Chronic Lung Allograft Dysfunction: Potential Marker for Biologic Subtyping Saito, T.
 2014
 33 4S p. S106-
1 p.
 artikel
540 New-onset Diabetes Mellitus Can Confer an Adverse Risk To Long-Term Survival After Heart Transplantation in Asian Patients Kim, H.
 2014
 33 4S p. S262-
1 p.
 artikel
541 NGS PBMC Transcriptome Analysis Identifies More Pronounced Activation of the Inflammatory Response in Advanced INTERMACS Class Before MCSD Implantation Bondar, G.
 2014
 33 4S p. S39-
1 p.
 artikel
542 No Difference in Pump Thrombosis in Heartmate II Patients With Gelatin Sealed and Unsealed Vascular Grafts Sundareswaran, K.S.
 2014
 33 4S p. S131-
1 p.
 artikel
543 Non-Adherence Is Associated With Mortality in Adolescent Lung Transplant Recipients Paraskeva, M.
 2014
 33 4S p. S223-
1 p.
 artikel
544 Non-invasive Functional Differentiation of PAH vs. PVH: Resting Hemodynamics vs. Exercise Gas Exchange Evaluation Pelaez, A.
 2014
 33 4S p. S53-S54
2 p.
 artikel
545 Non-Ischemic Dilated Cardiomyopathy: Biopsy Proved Markers of Disease Sub-Entities Rucinskas, K.
 2014
 33 4S p. S272-S273
2 p.
 artikel
546 Novel Antibody-Engineered Gold Nanoparticles as Targeted Drug Delivery for Primary Mesenchimal Cells Do Not Elicit an Inflammatory Response Meloni, F.
 2014
 33 4S p. S166-
1 p.
 artikel
547 Novel Lipoprotein Markers Remain Elevated Despite Statin Therapy After Heart Transplant Christopher, S.
 2014
 33 4S p. S284-S285
2 p.
 artikel
548 Novel Nomogram of the Immune Response After Heart Transplantation Bakir, M.
 2014
 33 4S p. S176-
1 p.
 artikel
549 Novel Two-Hit Hypothesis for the Development of De Novo Autoimmunity Following Lung Transplantation Bharat, A.
 2014
 33 4S p. S81-
1 p.
 artikel
550 Novel Use of a Nanoparticle Delivery System in an Ex-Vivo Model of Lung Transplantation Grimm, J.C.
 2014
 33 4S p. S254-S255
2 p.
 artikel
551 Once-Daily Tacrolimus: A Valuable Option Post Lung Transplantation Levvey, B.
 2014
 33 4S p. S187-S188
2 p.
 artikel
552 Optical Coherence Tomography in Pulmonary Arteries: A Proof of Concept Study Fenstad, E.R.
 2014
 33 4S p. S229-
1 p.
 artikel
553 Optimal Oxygenation in Lung Graft Circulation during Ex Vivo Lung Perfusion Noda, K.
 2014
 33 4S p. S48-
1 p.
 artikel
554 Optimization with Intra-aortic Balloon Counterpulsation Prior to Left Ventricular Assist Device Implantation Results in Improved Postoperative Outcomes Gdowski, M.
 2014
 33 4S p. S252-S253
2 p.
 artikel
555 Outcome After Transplantation of Lungs Evaluated With Ex-Vivo Lung Perfusion Wallinder, A.
 2014
 33 4S p. S192-
1 p.
 artikel
556 Outcome and Survival Following Cardiogenic Shock Supported By IABP Versus Mechanical Circulatory Support Devices in a National Cohort Stretch, R.J.
 2014
 33 4S p. S34-
1 p.
 artikel
557 Outcome of Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplantation: Institutional Experience Inci, I.
 2014
 33 4S p. S250-
1 p.
 artikel
558 Outcome of Pediatric Heart Transplantation Has Continued to Improve Over the Last Three Decades: Impact of Mechanical Circulatory Support Adachi, I.
 2014
 33 4S p. S223-S224
2 p.
 artikel
559 Outcomes After Heart Transplantation for Amyloid Cardiomyopathy in the Modern Era Davis, M.
 2014
 33 4S p. S51-
1 p.
 artikel
560 Outcomes and Survival Benefit of Lung Transplantation for Cystic Fibrosis: Single-Center Experience of 309 Consecutive Cases Machuca, T.N.
 2014
 33 4S p. S29-
1 p.
 artikel
561 Outcomes Following Pregnancy in Living Lobar Lung Transplantation Greene, C.L.
 2014
 33 4S p. S292-S293
2 p.
 artikel
562 Outcomes of Adult Patients with Small Body Size Supported with a Continuous-Flow Left Ventricular Assist Device Lee, S.
 2014
 33 4S p. S102-S103
2 p.
 artikel
563 Outcomes of Heart Transplant (HT) Recipients Bridged with BIVAD (BiVentricular Assist Device) Nsair, A.
 2014
 33 4S p. S77-S78
2 p.
 artikel
564 Outcomes of Heart vs. Heart-Liver Transplantation: UNOS Registry Analysis DePasquale, E.C.
 2014
 33 4S p. S158-
1 p.
 artikel
565 Outcomes of Intraoperative ECMO Versus Cardiopulmonary Bypass for Lung Transplantation Machuca, T.N.
 2014
 33 4S p. S29-S30
2 p.
 artikel
566 Outcomes of Lung Transplantation Using Donation after Cardiac Death Donors: Should We Use Ex Vivo Lung Perfusion? Machuca, T.N.
 2014
 33 4S p. S272-
1 p.
 artikel
567 Outcomes of Lung Transplant Recipients of Hepatitis B core Antibody Positive Donors Rokadia, H.K.
 2014
 33 4S p. S50-
1 p.
 artikel
568 Outcomes of Mechanical Circulatory Support in HIV Infected Patients from the INTERMACS Registry Pamboukian, S.V.
 2014
 33 4S p. S209-
1 p.
 artikel
569 Outcomes of Minimally Invasive Approach for Exchange of the HeartMate II (HMII) Left Ventricular Assist Device (LVAD) Soleimani, B.
 2014
 33 4S p. S201-
1 p.
 artikel
570 Outcomes of Patients Designated Bridge to Candidacy (BTC) at Time of LVAD With and Without Psychosocial Risks Factors: Implications for CMS Coverage Cruz, V.B.
 2014
 33 4S p. S64-
1 p.
 artikel
571 Outcomes of Patients Referred for a Left Ventricular Assist Device But Were Declined: The Recent-Era Forgotten Ones Johnson, A.K.
 2014
 33 4S p. S57-S58
2 p.
 artikel
572 Outcomes of Pediatric Heart Failure Referral Sparks, J.D.
 2014
 33 4S p. S307-
1 p.
 artikel
573 Outpatient Experience with Heartware® Ventricular Assist Device System in Children: A Multicenter Experience Schweiger, M.
 2014
 33 4S p. S18-S19
2 p.
 artikel
574 Over 400% Increase in LVAD Thrombosis Reported to the FDA’s Manufacturer and User Facility Device Experience (MAUDE) Database from 2010 to 2012 Wang, J.X.
 2014
 33 4S p. S9-S10
2 p.
 artikel
575 Overweight and Obesity Common after Lung Transplantation Anderson, J.L.
 2014
 33 4S p. S296-S297
2 p.
 artikel
576 Partial Flow with 15F Arterial Cannula Provides Sufficient Circulatory Support in Veno-Arterial Extracorporeal Membrane Oxygenation Landes, E.L.
 2014
 33 4S p. S250-
1 p.
 artikel
577 Patient Risk Stratification by Early Identification of Systemic Inflammatory Response via T cell Immunophenotyping at Time of Mechanical Circulatory Support Device Implantation Schaenman, J.M.
 2014
 33 4S p. S233-
1 p.
 artikel
578 Patients With Cystic Fibrosis Have a Better Recovery in Exercise Capacity and Quadriceps Muscle Strength Post-Lung Transplant Walsh, J.
 2014
 33 4S p. S301-S302
2 p.
 artikel
579 Patterns of Readmission With Contemporary Continuous Flow Circulatory Support Hernandez, R.
 2014
 33 4S p. S199-
1 p.
 artikel
580 PCC for Warfarin Reversal in High Risk Pediatric Cardiac Transplantation Haney, A.L.
 2014
 33 4S p. S313-
1 p.
 artikel
581 Pediatric Cardiac Re-transplantation: Waitlist Mortality Stratified by Age and Era Bock, M.
 2014
 33 4S p. S111-S112
2 p.
 artikel
582 Pediatric Heart Transplant Waitlist Mortality in the Era of Ventricular Assist Devices Zafar, F.
 2014
 33 4S p. S18-
1 p.
 artikel
583 Pediatric Lung Transplant Patients with Cystic Fibrosis Need High Voriconazole Dosing to Achieve Therapeutic Drug Levels Melicoff, E.
 2014
 33 4S p. S224-
1 p.
 artikel
584 Perceived Control: A Target for Improving Psychosocial Outcomes Early After Heart Transplant Doering, L.
 2014
 33 4S p. S32-S33
2 p.
 artikel
585 Percutaneous Balloon Occlusion of a Left Ventricular Assist Device Outflow Cannula During Right Heart Catheterization With Pumpstop as Part of the Evaluation of Myocardial Recovery Vierecke, J.
 2014
 33 4S p. S156-
1 p.
 artikel
586 Percutaneous Implantation of a Novel Interatrial Shunt Device in Patients with Heart Failure and Preserved or Mildly Reduced Ejection Fraction: Initial Results of a Pilot Trial Gustafsson, F.
 2014
 33 4S p. S78-
1 p.
 artikel
587 Percutaneous Insertion of Veno-Arterial Extracorporeal Membrane Oxygenation Circuit in the Catherization Laboratory for Refractory Cardiogenic Shock Is Safe and Associated with Excellent Outcomes Sandoval, Y.
 2014
 33 4S p. S103-
1 p.
 artikel
588 Performance of (1,3)-β- D-Glucan in Bronchoalveolar Lavage of Lung Transplant Recipients (LTRs) for the Diagnosis of Invasive Pulmonary Aspergillosis (IPA) Bhaskaran, A.
 2014
 33 4S p. S152-
1 p.
 artikel
589 Performance of Gene Expression Profiling Variability in Discriminating Heart Transplant Patients at Risk for Future Clinical Events Crespo-Leiro, M.G.
 2014
 33 4S p. S277-
1 p.
 artikel
590 Performance Status Impacts Mortality Following Lung Transplantation Grimm, J.C.
 2014
 33 4S p. S80-
1 p.
 artikel
591 Perioperative Venous Thromboembolism Prophylaxis in Lung Transplant Patients McGugan, P.L.
 2014
 33 4S p. S293-
1 p.
 artikel
592 Peripheral Pulse Wave Analysis Technique to Detect Aortic Valve State in Continuous-flow LVADs Singal, A.
 2014
 33 4S p. S75-
1 p.
 artikel
593 Peripheral Veno-Arterial ECMO as a Bridge To Heart Transplantation: Outcomes From a Single-Centre Experience Poptsov, V.N.
 2014
 33 4S p. S247-S248
2 p.
 artikel
594 Persistent Blood Stream Infections Are Associated with Cerebrovascular Accidents in Patients with Continuous Flow LVADs Trachtenberg, B.H.
 2014
 33 4S p. S21-S22
2 p.
 artikel
595 Persistent Hyperbilirubinemia Following LVAD Implantation Predicts Postoperative Multisystem Organ Failure and Mortality Lavine, K.J.
 2014
 33 4S p. S62-
1 p.
 artikel
596 Pharmacological Inhibition of Peroxynitrite and Poly (ADP-ribose) Polymerase during Ex-vivo Lung Perfusion (EVLP) Markedly Reduces Ischemia-reperfusion Injury in the Explanted Donor Lung Wang, X.
 2014
 33 4S p. S26-S27
2 p.
 artikel
597 Phenotypes of Chronic Lung Allograft Dysfunction (CLAD): A Multilevel Diagnostic Approach Koutsokera, A.
 2014
 33 4S p. S70-
1 p.
 artikel
598 Phenprocoumon in Heartware Ventricular Assist Device Patients - A New Regimen for Early Postoperative Anticoagulation Schneeberger, Y.
 2014
 33 4S p. S314-
1 p.
 artikel
599 Physical Exercise Reduces Transplant Arteriosclerosis in a Fully Allogeneic Mouse Aorta Transplantation Model Knöfel, A.K.
 2014
 33 4S p. S164-S165
2 p.
 artikel
600 Physical Outcomes Post Paediatric Lung Transplant - Implications of Extra-Corporeal Membrane Oxygenation (ECMO) Tarrant, B.J.
 2014
 33 4S p. S125-
1 p.
 artikel
601 Pig Artery Patch Transplantation (Tx) in Nonhuman Primates (NHPs): A Predictor of Outcome of PIG-To-NHP Heart Tx Iwase, H.
 2014
 33 4S p. S108-
1 p.
 artikel
602 Pioglitazone for the Treatment of Insulin Resistance in Heart Transplant Recipients: Assessment of Efficacy and Safety Ray, R.
 2014
 33 4S p. S282-S283
2 p.
 artikel
603 Plasma Lipid Peroxidation Products Are Higher in Lung Transplant Recipients with PGD and Are Associated with Donor Smoking Ware, L.B.
 2014
 33 4S p. S186-S187
2 p.
 artikel
604 Plasma Protein Biosignatures for Detection of Cardiac Allograft Vasculopathy Toma, M.
 2014
 33 4S p. S25-S26
2 p.
 artikel
605 Post Cardiopulmonary Bypass Vasoplegic Syndrome in Continuous Flow Left Ventricular Assist Devices Is Associated With Adverse Outcomes Chen, M.
 2014
 33 4S p. S132-
1 p.
 artikel
606 Post Heart Transplantation Outcomes of Heart Mate II Bridged Patients Requiring Concomitant Temporary Right Ventricular Mechanical Support Urban, M.
 2014
 33 4S p. S260-
1 p.
 artikel
607 Post Heart Transplant (HT) Survival in Pediatric Patients with Left Ventricular and Biventricular Assist Devices (LVAD/BIVAD): UNOS Registry Analysis Reardon, L.C.
 2014
 33 4S p. S307-
1 p.
 artikel
608 Post Mortem Confirmation of Chronic Lung Allograft Dysfunction Malouf, M.A.
 2014
 33 4S p. S42-
1 p.
 artikel
609 Postoperative Donor Specific Anti-HLA Antibodies in Lung Transplantation: Risk Factors and Impact on Mid-Term Patient and Graft Outcomes Ius, F.
 2014
 33 4S p. S159-
1 p.
 artikel
610 Post-operative Hyperbilirubenemia in Predicting Morbidity and Mortality Associated with Continuous Left Ventricular Assist Implantation Kumar, S.
 2014
 33 4S p. S214-
1 p.
 artikel
611 Post-Transplant Outcomes of Pediatric Patients Bridged with Continuous Flow Left Ventricular Assist Devices Levin, A.
 2014
 33 4S p. S306-S307
2 p.
 artikel
612 Preconditioning Lung Grafts with Inhaled Hydrogen during Ex Vivo Lung Perfusion Improves Posttransplant Lung Grafts Function Noda, K.
 2014
 33 4S p. S27-
1 p.
 artikel
613 Preconditioning of Naïve and Activated Endothelial Cells With Induction Agents Modulates Endothelial Cell Function: Non-Depleting Vs. Depleting Agents Werner, I.
 2014
 33 4S p. S67-
1 p.
 artikel
614 Predicting Heart Transplant Outcomes: Do We Have a Reliable Instrument to Assess Psychosocial Risk? Vandenbogaart, E.
 2014
 33 4S p. S171-
1 p.
 artikel
615 Predicting Peri-operative Right Heart Failure, Post-implant Survival and Timing of Mechanical Ventricular Assistance Harb, M.
 2014
 33 4S p. S58-
1 p.
 artikel
616 Predicting Survival in Heart Failure Patients With an Implantable Cardioverter Defibrillator: The Heart Failure Meta-Score Alba, A.C.
 2014
 33 4S p. S52-
1 p.
 artikel
617 Prediction of Hemostatic Dysfunction in Patients Implanted with the HeartMate II LVAD Walenga, J.M.
 2014
 33 4S p. S243-
1 p.
 artikel
618 Predictive Value of PAPP-A, sCD40L, Anti-HLA Antibodies Detected By ELISA and Luminex in Heart Transplant Recipients Shevchenko, O.P.
 2014
 33 4S p. S135-
1 p.
 artikel
619 Predictors of Anxiety and Depression during the First 2 Months after Lung Transplantation Alrawashdeh, M.O.
 2014
 33 4S p. S190-
1 p.
 artikel
620 Predictors of Late Renal Dysfunction after Pediatric Heart Transplantation: A UNOS Database Analysis Molina, K.
 2014
 33 4S p. S111-
1 p.
 artikel
621 Predictors of Long-Term Survival after Pediatric Heart Transplantation Change with Age Khan, M.S.
 2014
 33 4S p. S121-
1 p.
 artikel
622 Predictors of Mortality in Heart Transplant Candidates With or Without Mechanical Circulatory Support: A French National Study Jasseron, C.
 2014
 33 4S p. S268-S269
2 p.
 artikel
623 Predictors of Physical Activity in a Pre-Lung Transplant Population Walsh, J.R.
 2014
 33 4S p. S302-
1 p.
 artikel
624 Pre-emptive ID Specialist Consultation Reduces MCS Drive Line Infections Hadi, A.
 2014
 33 4S p. S129-
1 p.
 artikel
625 Pre-Emptive Treatment of Donor Specific Anti-HLA Antibodies in Lung Transplantation With Plasmapheresis Ius, F.
 2014
 33 4S p. S160-S161
2 p.
 artikel
626 Pre-Heart Transplant Recipient Counterpulsation Influences Primary Graft Dysfunction But Not Survival: Analysis of a National Cohort Jawitz, N.G.
 2014
 33 4S p. S275-S276
2 p.
 artikel
627 Preliminary Results from the C-Pulse® System European Multicenter Study Schulz, A.
 2014
 33 4S p. S205-
1 p.
 artikel
628 Preliminary Results of a Phase II Trial Comparing Outcomes of Patients Transplanted with Lungs from Uncontrolled Donation After Cardiac Death Donors (uDCDDs) Assessed with Ex-vivo Lung Perfusion (EVLP) to Lungs from Conventional Brain-Dead Donors Egan, T.
 2014
 33 4S p. S17-
1 p.
 artikel
629 Preliminary Single-center Experience with Left Anterior Mini-thoracotomy for Continuous-flow LVAD Implantation Rodrigo, M.E.
 2014
 33 4S p. S202-
1 p.
 artikel
630 Preoperative Risk Factors for Early Mortality in Patients Bridged to Transplant with a Continuous Flow Left Ventricular Assist Device Healy, A.H.
 2014
 33 4S p. S56-
1 p.
 artikel
631 Presence of C3d Fixing HLA Antibodies Carries Worse Prognosis and Is Associated With Increased Allograft Vasculopathy in Heart Transplant (HT) Patients Ducreux, S.
 2014
 33 4S p. S176-S177
2 p.
 artikel
632 Presence of Coronary Artery Fistulae after Cardiac Transplantation Is Associated with Increased Plaque Progression by Intravascular Ultrasound Cheng, R.
 2014
 33 4S p. S284-
1 p.
 artikel
633 Pressure-Volume Relations in Patients Supported With Continuous-Flow Left Ventricular Assist Devices: A Comparative Descriptive Study of Invasive Hemodynamics Versus Echocardiography Jung, M.H.
 2014
 33 4S p. S14-
1 p.
 artikel
634 Pre-Transplant Anti-HLA Antibodies and Clinical Events After Heart Transplantation Gazdic, T.
 2014
 33 4S p. S278-
1 p.
 artikel
635 Pre-transplant Chemotherapy Does Not Affect Cardiac Transplant Survival in Light-Chain Amyloid Patients Sarswat, N.
 2014
 33 4S p. S51-S52
2 p.
 artikel
636 Prevalence and Impact of Anti-DPα/ DPβ /DQα HLA Antibodies in De Novo Heart Transplantation Goldraich, L.
 2014
 33 4S p. S285-S286
2 p.
 artikel
637 Prevalence and Predictors of Diabetes After Lung Transplantation Hackman, K.L.
 2014
 33 4S p. S296-
1 p.
 artikel
638 Prevalence of BK Polyomavirus Infection and Association with Renal Function in Pediatric Heart Transplant Recipients Ducharme-Smith, A.L.
 2014
 33 4S p. S122-
1 p.
 artikel
639 Prevalence of Forgut Dysfunction in Pulmonary Fibrosis and COPD Patients Undergoing LTx Evaluation Hooft, N.
 2014
 33 4S p. S299-S300
2 p.
 artikel
640 Prevalence of Gastroparesis After Lung Transplantation: A Single Center Study Jhun, H.
 2014
 33 4S p. S288-S289
2 p.
 artikel
641 Prevalence of Late Right Ventricular Dysfunction After Left Ventricular Assist Device Implantation Roberts, E.
 2014
 33 4S p. S239-
1 p.
 artikel
642 Prevalence of Vitamin D Deficiency Among LVAD Patients Knappe, D.
 2014
 33 4S p. S208-
1 p.
 artikel
643 Primary Graft Dysfunction Is Related To Extravascular Lung Water During Ex Vivo Lung Perfusion Trebbia, G.
 2014
 33 4S p. S47-S48
2 p.
 artikel
644 Prior Hematological Disorders Carry a High Morbidity and Mortality in Patients Supported with Continuous Flow Left Ventricular Assist Devices Fried, J.
 2014
 33 4S p. S72-
1 p.
 artikel
645 Probe-based Confocal Laser Endo-microscopy (pCLE) Can Identity Perivascular Cellular Infiltration in Patients with Acute Cellular Rejection Keller, C.A.
 2014
 33 4S p. S69-S70
2 p.
 artikel
646 Process Improvement in Thoracic Organ Donor Retrieval: Implementation of a Donor Assessment Checklist Loor, G.
 2014
 33 4S p. S270-
1 p.
 artikel
647 Profile of Heart Transplant Recipients in a Brazilian Center: Comparison With International Registry Seguro, L.F.
 2014
 33 4S p. S264-
1 p.
 artikel
648 Prognostic Significance and Long-Term Evolution of Resting Heart Rate After Heart Transplantation Barge-Caballero, E.
 2014
 33 4S p. S133-
1 p.
 artikel
649 Progression of Left Ventricular Dysfunction in Duchenne and Becker Muscular Dystrophies Ridall, L.
 2014
 33 4S p. S305-S306
2 p.
 artikel
650 Proliferation Signal Inhibitors for Cardiac Allograft Vasculopathy in Heart Transplant Recipients: A Systematic Review and Meta-Analysis of Randomized Clinical Trials Greig, D.
 2014
 33 4S p. S16-
1 p.
 artikel
651 Proliferative Signal Inhibitor and Deep Vein Thrombosis: Is There a Connection? Patel, J.
 2014
 33 4S p. S276-S277
2 p.
 artikel
652 Prolonged Intensive Care Unit Stay after Bilateral Lung Transplantation - Late Mortality & Functional Outcome? Ong, L.P.
 2014
 33 4S p. S294-
1 p.
 artikel
653 Prolonged Ischemia Does Not Affect Survival Following Lung Transplantation Grimm, J.C.
 2014
 33 4S p. S50-
1 p.
 artikel
654 Protective Effect of β−2 Adrenoreceptor Agonist Inhalation During Ex Vivo Lung Perfusion Kondo, T.
 2014
 33 4S p. S48-S49
2 p.
 artikel
655 Protein Kinase C delta-Mediated Unfolded Protein Response and Necrotic Cell Death Contributes to Ischemia-Reperfusion Induced Injury in Lung Transplantation Kim, H.
 2014
 33 4S p. S83-
1 p.
 artikel
656 Psychosocial Assessment of Candidates for Transplantation Score and Readmissions in HeartMate II Bridge to Transplant Left Ventricular Assist Device Patients Schettle, S.
 2014
 33 4S p. S219-
1 p.
 artikel
657 Psychosocial Factors Do Not Influence Survival or the Development of Complications After Left Ventricular Assist Device Implantation Golwala, H.
 2014
 33 4S p. S89-
1 p.
 artikel
658 Pulmonary Artery Pulsatility Index Predicts Right Ventricular Failure After LVAD Implantation Kang, G.
 2014
 33 4S p. S86-
1 p.
 artikel
659 Pulmonary Function and Exercise Tolerance of Lung Transplanted Patients With Initially Rejected Grafts Reconditioned With Ex-Vivo Lung Perfusion: Medium Term Results Boffini, M.
 2014
 33 4S p. S286-
1 p.
 artikel
660 Pulmonary Vasodilators Can Reverse Out-of-Proportional Pulmonary Hypertension in Patients with Left Cardiac Disease Maki, H.
 2014
 33 4S p. S311-
1 p.
 artikel
661 Pulmonary Vasodilators Early and in High Dose Improve Outcomes and Reduce Right Ventricular Failure After Left Ventricular Device Implantation Critoph, C.H.
 2014
 33 4S p. S239-S240
2 p.
 artikel
662 Quality of Life and Metrics of Achievement in Long-Term Adult Survivors of Pediatric Heart Transplant Hollander, S.A.
 2014
 33 4S p. S110-
1 p.
 artikel
663 Race/Ethnic Differences in the Epidemiology of Graft Failure in a Contemporary Cohort Morris, A.A.
 2014
 33 4S p. S90-
1 p.
 artikel
664 Rapid and Combined Measurement of Cyclosporin A, Tacrolimus, Sirolimus and Everolimus in Whole Blood and Dried Blood Spot With LC-MSMS Egas, A.C.
 2014
 33 4S p. S68-
1 p.
 artikel
665 Rapid Inpatient Titration of Intravenous Treprostinil for Severe Pulmonary Arterial Hypertension Hansen, L.
 2014
 33 4S p. S309-
1 p.
 artikel
666 Readmission after Left Ventricular Assist Device Implantation: Differences Observed Between Two Device Types Maltais, S.
 2014
 33 4S p. S101-
1 p.
 artikel
667 Real-Time Imaging With the O-Arm of Lung Parenchyma During Ex-Vivo Lung Reconditioning Sage, E.
 2014
 33 4S p. S258-S259
2 p.
 artikel
668 Reconstitution of CMV-Specific Immunity After Heart Transplantation May Guide Customization of Immunosuppressive and Antiviral Strategies: A Prospective Randomized Study Potena, L.
 2014
 33 4S p. S154-S155
2 p.
 artikel
669 Recovery of Myocardial Capillary Bed (Microvascular) Density Persists in Long Term Follow Up of CAV Patients Treated With Sirolimus Miller, D.V.
 2014
 33 4S p. S280-
1 p.
 artikel
670 Recurrent LV Dilation After Initial Decompression with Continuous-flow Left Ventricular Assist Device (CFLVADS): Implications on Long Term Survival Yingchoncharoen, T.
 2014
 33 4S p. S213-
1 p.
 artikel
671 Reduced Long-term Outcomes after Orthotopic Heart Transplantation in Septuagenarians Yerebakan, H.
 2014
 33 4S p. S55-
1 p.
 artikel
672 REduce Driveline Trauma through StabIlization and Exit Site ManagemenT: Results of the RESIST Study Stahovich, M.
 2014
 33 4S p. S207-S208
2 p.
 artikel
673 Reduced Survival in Lambda Predominant Cardiac AL Amyloidosis Patients Awaiting Heart Transplant Tabtabai, S.
 2014
 33 4S p. S52-
1 p.
 artikel
674 Reducing 30 Day Hospital Readmissions for Patients with Left Ventricular Support Devices Starling, R.C.
 2014
 33 4S p. S198-
1 p.
 artikel
675 Reduction in Driveline Infection Rates: Results from the HeartMate II Multicenter Silicone-Skin-Interface (SSI) Registry Dean, D.
 2014
 33 4S p. S11-S12
2 p.
 artikel
676 Reduction of Drive Line Infection in Continuous Flow Assist Devices: Use of Standard Kit Including Silver Dressing and Anchoring Device Cagliostro, B.
 2014
 33 4S p. S102-
1 p.
 artikel
677 Refusing Donors for HLA Sensitization Reasons Results in Increased Mortality in Pediatric Heart Transplant Candidates Richmond, M.E.
 2014
 33 4S p. S150-
1 p.
 artikel
678 Regenerative Stem Cell Transplantation: Biological and Immunogenic Differences Between Infant and Aged Cells Stubbendorff, M.
 2014
 33 4S p. S257-
1 p.
 artikel
679 Regional Differences in Utilization and Outcomes of Left Ventricular Assist Devices: Insights from the INTERMACS Registry Krim, S.R.
 2014
 33 4S p. S72-S73
2 p.
 artikel
680 Regression of Cellular Hypertrophy Leads to Functional Recovery Following Implantation with Centrifugal Continuous Flow Left Ventricular Assist Devices Muthiah, K.
 2014
 33 4S p. S236-
1 p.
 artikel
681 Regulation of Host Immunity By Donor B Cells in Neonatal Tolerance To Cardiac Allografts Bascom, R.A.
 2014
 33 4S p. S109-S110
2 p.
 artikel
682 Regulatory T Cells Attenuate Chronic Rejection by Suppressing T Helper 17 Cells Differentiation after Murine Lung Transplantation Zhou, W.
 2014
 33 4S p. S82-
1 p.
 artikel
683 Relationship Between Anti-HLA Antibodies and Coronary Allograft Vasculopathy after Heart Transplantation Khandhar, S.J.
 2014
 33 4S p. S178-S179
2 p.
 artikel
684 Relationship Between Candidate Psychosocial Risk Profile, Post-Implant Medical Compliance and Clinical Outcomes of LVAD Therapy Woodhouse, K.
 2014
 33 4S p. S126-
1 p.
 artikel
685 Relationship Between Speed and Left Ventricular Size in HVAD Patients: Lessons from the HVAD Ramp Test Study Uriel, N.
 2014
 33 4S p. S12-S13
2 p.
 artikel
686 Relationship Between the Cost and Cause of Hospital Readmissions After LVAD Implantation Lietz, K.
 2014
 33 4S p. S101-S102
2 p.
 artikel
687 Relative Importance of Antibodies Against Class I and Class II Human Leukocyte Antigens on Graft Survival in Pediatric Heart Transplant Recipients: An Analysis of the United Network for Organ Sharing Database O’Connor, M.J.
 2014
 33 4S p. S124-
1 p.
 artikel
688 Reliability of Echocardiographic Measurements of Left Ventricular Function in Potential Pediatric Heart Transplant Donors Chen, S.
 2014
 33 4S p. S224-S225
2 p.
 artikel
689 Renal Allograft Outcome after Simultaneous Heart and Kidney Transplantation Grupper, A.
 2014
 33 4S p. S66-
1 p.
 artikel
690 Renal Impairment Post VAD Implantation in Patients With Normal Pre-operative Renal Function Lui, R.
 2014
 33 4S p. S199-S200
2 p.
 artikel
691 Renal Injury Persists Following LVAD Despite Significant Improvement in Glomerular Filtration Rate: Preliminary Insights From Urinary Injury Biomarkers Brisco, M.A.
 2014
 33 4S p. S75-S76
2 p.
 artikel
692 Reproducibility of C4d by Immunofluorescence and Immunohistochemistry in Routine Lung Allograft Biopsies Roden, A.C.
 2014
 33 4S p. S113-
1 p.
 artikel
693 Resource and Cost Evaluation of a Destination Therapy Ventricular Assist Device Program Barbone, A.
 2014
 33 4S p. S46-
1 p.
 artikel
694 Restrictive Allograft Syndrome (RAS) in Lung Transplant Recipients Carries Uncertain Additional Prognostic Significance as Compared To BOS Schultz, H.L.
 2014
 33 4S p. S71-
1 p.
 artikel
695 Restrictive Cardiomyopathy and Risk of Mortality on Waiting List for Heart Transplantation Hsich, E.M.
 2014
 33 4S p. S66-S67
2 p.
 artikel
696 RESULT (Reflux Surgery in Lung Transplantation) To Determine If Prevention of GERD Related Aspiration By Surgical Fundoplication Improves Lung Allograft Function. Sponsor: National Heart, Lung, and Blood Institute (NHLBI) Davis, D.
 2014
 33 4S p. S41-
1 p.
 artikel
697 Resurrection of ECMO in India and the Initial Experience in Cardiorespiratory Failure Krishan, K.
 2014
 33 4S p. S266-
1 p.
 artikel
698 Retransplantation Versus Medical Therapy for Cardiac Allograft Vasculopathy (CAV): Analysis of the International Society for Heart and Lung Transplantation (ISHLT) Registry Goldraich, L.
 2014
 33 4S p. S90-
1 p.
 artikel
699 Retrospective Analysis of HVAD® Pump Controller Log Data and Its Significance to Physiological Events Brown, M.C.
 2014
 33 4S p. S204-S205
2 p.
 artikel
700 Right Ventricular Assist Device Support After Continuous Flow Left Ventricular Assist Device Implantation: Predicting a Poor Predictor Singh, S.K.
 2014
 33 4S p. S237-S238
2 p.
 artikel
701 Right Ventricular Dysfunction Is Associated with Gastrointestinal Bleeding in Patients Supported with Continuous-Flow LVADs Sparrow, C.T.
 2014
 33 4S p. S12-
1 p.
 artikel
702 Right Ventricular Dyssynchrony in Idiopathic Pulmonary Arterial Hypertension: Insights From Echocardiographic and Cardiac Magnetic Resonance Imaging Badagliacca, R.
 2014
 33 4S p. S229-
1 p.
 artikel
703 Right Ventricular Function and Pulmonary Artery Compliance Improve with Phosphodiesterase type 5A (PDE5A) Inhibitor Therapy in Pulmonary Hypertension Patarroyo Aponte, M.M.
 2014
 33 4S p. S230-S231
2 p.
 artikel
704 Right Ventricular Recovery Following Lung Transplantation: Does it happen? Addetia, K.
 2014
 33 4S p. S298-
1 p.
 artikel
705 Right Ventricular Remodeling in Idiopathic Pulmonary Arterial Hypertension: Concentric Versus Eccentric Hypetrophy Badagliacca, R.
 2014
 33 4S p. S148-
1 p.
 artikel
706 Right Ventriculo-Arterial Coupling in Patients With Pulmonary Arterial Hypertension Undergoing Rapid Dose Escalation of Treprostinil Rischard, F.
 2014
 33 4S p. S230-
1 p.
 artikel
707 Risk Factor Analysis for Individual Causes of Death Following Pediatric Heart Transplant: An Analysis of the ISHLT Registry Vanderlaan, R.D.
 2014
 33 4S p. S44-S45
2 p.
 artikel
708 Risk Factors for Sudden Death in Children with Cardiac Allograft Vasculopathy Hong, B.J.
 2014
 33 4S p. S122-S123
2 p.
 artikel
709 Risk-Stratification in Children with Advanced Heart Failure Using Hemodynamic Data Alexander, P.M.
 2014
 33 4S p. S302-
1 p.
 artikel
710 RNAseq Identifies Novel Potential Right Ventricular Biomarkers in Human Heart Failure Di Salvo, T.
 2014
 33 4S p. S232-S233
2 p.
 artikel
711 Robotic Implantation of Left Ventricular Assist Devices: A New Era in Cardiac Surgery Khalpey, Z.
 2014
 33 4S p. S202-
1 p.
 artikel
712 Role of Coronary CT in Predicting Cardiovascular Prognosis After Heart Transplantation Masetti, M.
 2014
 33 4S p. S174-
1 p.
 artikel
713 Role of Pentaxrin 3 in Differentiating Invasive Aspergillosis (IA) from Aspergillus Colonization (Ac) in Lung Transplant Recipients Kabbani, D.
 2014
 33 4S p. S152-S153
2 p.
 artikel
714 Role of Serial Measurement of Peak Oxygen Consumption for Prognosis Assessment in Heart Failure Alba, A.C.
 2014
 33 4S p. S171-S172
2 p.
 artikel
715 Role of VAD Therapy for Patients with Restrictive Cardiomyopathy: Improving Outcomes for a Lethal Disease Grupper, A.
 2014
 33 4S p. S85-
1 p.
 artikel
716 Routine Endomyocardial Biopsies Beyond the First Year Have Low Diagnostic Utility in Heart Transplant Recipients Fattah, I.A.
 2014
 33 4S p. S175-
1 p.
 artikel
717 Running with a VAD Fuller, L.M.
 2014
 33 4S p. S222-
1 p.
 artikel
718 RV Fractional Area Change at 6 Months But Not at Pre-Implant Is Associated with Late Indices of Functional Capacity and Renal Function: A Case for the Importance of Late RV Dysfunction in Long Term MCS Rame, J.
 2014
 33 4S p. S238-S239
2 p.
 artikel
719 Safety and Efficacy of Pre Transplant Desensitization of Patients Supported by CF-LVADs Mody, K.P.
 2014
 33 4S p. S99-S100
2 p.
 artikel
720 Safety, Feasibility and Time Requirement of Echocardiography Pump Speed Change Testing in Patients With Continuous-Flow Left Ventricular Assist Devices Estep, J.D.
 2014
 33 4S p. S215-
1 p.
 artikel
721 Safety of Anticoagulation Reversal in Patients Supported With Continuous-Flow Left-Ventricular Assist Devices Jennings, D.L.
 2014
 33 4S p. S313-
1 p.
 artikel
722 Safety of Intravascular Ultrasound in Nearly 900 Cases Baran, D.A.
 2014
 33 4S p. S172-
1 p.
 artikel
723 Safety of Mechanical Circulatory Support as a Bridge to Cardiac Retransplantation Thomas, S.S.
 2014
 33 4S p. S101-
1 p.
 artikel
724 Safety of Nurse Driven Ambulation for Patients on Venovenous Extracorporeal Membrane Oxygenation Dennis, D.R.
 2014
 33 4S p. S301-
1 p.
 artikel
725 Sarcopenia Is Associated with Increased Post Left Ventricular Assist Device Implantation Morbidity Xu, W.D.
 2014
 33 4S p. S212-
1 p.
 artikel
726 Second Report of Japanese registry for Mechanically Assisted Circulatory Support (J-MACS) Nakatani, T.
 2014
 33 4S p. S60-S61
2 p.
 artikel
727 Sensitized VADs vs. Sensitized Non-VADs: Is There an Immunological Difference? Kobashigawa, J.
 2014
 33 4S p. S305-
1 p.
 artikel
728 Serum Hepcidin Antimicrobial Peptide Levels Predict Infection After Lung Transplantation Ross, D.J.
 2014
 33 4S p. S289-
1 p.
 artikel
729 Serum KL-6 Levels Are Associated With Long-Term Prognosis in Lung Transplant Recipients Besa, V.
 2014
 33 4S p. S190-S191
2 p.
 artikel
730 Serum Markers of Vascular Angiogenesis and Inflammation Are Predictive of Functional Capacity and Invasive Hemodynamics in Patients with Pulmonary Arterial Hypertension Raina, A.
 2014
 33 4S p. S311-
1 p.
 artikel
731 Severity of End Organ Damage as a Predictor of Outcomes after Implantation of Continuous Flow Left Ventricular Assist Devices (LVAD) as Bridge to Transplantation (BTT) Soleimani, B.
 2014
 33 4S p. S211-S212
2 p.
 artikel
732 Sexual Dimorphism in Lung Inflammatory Process After Brain Death Induction in Rats Moreira, L.P.
 2014
 33 4S p. S166-
1 p.
 artikel
733 Sildenafil Attenuates Lung Ischemia-Reperfusion Injury in a Rodent Model Cobb, J.A.
 2014
 33 4S p. S288-
1 p.
 artikel
734 Single Lung Transplantation in Patients with Secondary Pulmonary Hypertension Is Safe and Organ Efficient Julliard, W.
 2014
 33 4S p. S295-
1 p.
 artikel
735 Single Lung Transplantation in the United States: What Happens To the Other Lung? Speicher, P.J.
 2014
 33 4S p. S45-S46
2 p.
 artikel
736 Single Nucleotide Polymorphisms, SNPs, Associated With the Efficacy and Security of Immunosuppressive Treatment in Heart Transplantation Sanchez-Lazaro, I.
 2014
 33 4S p. S146-
1 p.
 artikel
737 Sirolimus Improves Renal Function and May Prevent BOS Progression After Lung Transplant Mariski, M.
 2014
 33 4S p. S190-
1 p.
 artikel
738 Sirolimus Is Associated With Worse Renal Function in a Tacrolimus Based Immunosuppressive Regimen in Lung Transplantation Robinson, M.
 2014
 33 4S p. S291-
1 p.
 artikel
739 Size Matters: Impact of Pump Size of Berlin Heart EXCOR Pediatric Device on Clinical Outcome in Children Miera, O.
 2014
 33 4S p. S19-
1 p.
 artikel
740 Smoking and Mortality in the Waiting for a New Heart Study Weidner, G.
 2014
 33 4S p. S300-S301
2 p.
 artikel
741 S-Nitroso Human Serum Albumin Vs Inhaled Nitric Oxide in Experimental Right Ventricular Failure on Prolonged Overcirculation-Induced Pulmonary Hypertension Rungatscher, A.
 2014
 33 4S p. S309-S310
2 p.
 artikel
742 Social Framework of Pediatric Heart Recipients Who Have Survived More Than 15 Post Transplant Years: A Single Center Experience Copeland, H.
 2014
 33 4S p. S110-S111
2 p.
 artikel
743 Socio-Economic Classification Is a Predicator of Long Term Survival in Patients With Left Ventricualr Assist Device Robinson Smith, N.
 2014
 33 4S p. S127-
1 p.
 artikel
744 Soluble Vascular Endothelial Growth Factor Receptor -1 (sFlt-1) Is Decreased in Patients With Pulmonary Arterial Hypertension Selimovic, N.
 2014
 33 4S p. S312-
1 p.
 artikel
745 Spectrum and Etiologies of Ventricular Assist Device Infections: A Single Center Study Stosor, V.
 2014
 33 4S p. S22-
1 p.
 artikel
746 SPHERIC-1 (Sildenafil and Pulmonary HypERtension in COPD): Intention-to-Treat (ITT) Analysis of Safety and Efficacy Data Vitulo, P.
 2014
 33 4S p. S148-S149
2 p.
 artikel
747 Stabilin-1: A Possible Functional Biomarker for Pro-Fibrotic Alternative Macrophage Activation in Dilatative Cardiomyopathy Patients With Left Ventricular Assist Device Implantation Wassilew, K.
 2014
 33 4S p. S62-
1 p.
 artikel
748 Static Versus Dynamic Angiographic CAV Evaluation: Prognostic Stratification Beyond ISHLT Grading Masetti, M.
 2014
 33 4S p. S83-S84
2 p.
 artikel
749 Steroids Withdrawal During the First Year After Heart Transplantation and Its Association With Changes in Renal Function in a Two Year Follow-Up. RESTCO Study Crespo-Leiro, M.G.
 2014
 33 4S p. S174-S175
2 p.
 artikel
750 Stromal-Derived Factor-1 (SDF-1) Expression is Downregulated After Chronic Continuous Flow Left Ventricular Assist Device (CF-LVAD) Support Godier-Furnemont, A.
 2014
 33 4S p. S235-
1 p.
 artikel
751 Strong Correlation Between Alere Home INR and Core Lab INR in Patients Supported with CF-LVAD Dionizovik-Dimanovski, M.
 2014
 33 4S p. S241-
1 p.
 artikel
752 Structural Remodeling of the Cardiac Ventricles: When Left Isn’t Equally Right Diakos, N.
 2014
 33 4S p. S170-
1 p.
 artikel
753 Struggle for (Graft-) Survival: Long-Term Results Comparing Standard Therapy With Tacrolimus/Mycophenolate Mofetil Versus De-Novo Low-Dose Tacrolimus/Sirolimus Therapy 10 Years After Heart Transplantation Guethoff, S.
 2014
 33 4S p. S134-
1 p.
 artikel
754 Study of Burkholderia Cepacia Complex Strains in Lung Transplant Patients: Analysis of Genomovar and Mortality Impact Carraro, D.S.
 2014
 33 4S p. S182-
1 p.
 artikel
755 Subcostal vs. Sternotomy Device Exchanges: Comparison of Long-Term Mortality and Re-Exchange Levin, A.P.
 2014
 33 4S p. S129-S130
2 p.
 artikel
756 Successful LVAD Therapy in Patients Ineligible for Heart Transplantation Due to Psychosocial Considerations Rajagopalan, N.
 2014
 33 4S p. S219-S220
2 p.
 artikel
757 Successful Use of Cidofovir and Leflunomide in Lung Transplant Recipient with BK Polyomavirus Encephalitis Ong, P.
 2014
 33 4S p. S31-S32
2 p.
 artikel
758 Success of Left Ventricular Assist Device Therapy in Uninsured Patients Rajagopalan, N.
 2014
 33 4S p. S127-
1 p.
 artikel
759 Supplementation of Hypogammaglobulinemia in Lung Transplant Recipients Leads to Favorable Outcomes Tsuang, W.M.
 2014
 33 4S p. S69-
1 p.
 artikel
760 Surgical LVAD Placement Significantly Reduces Mitral Regurgitation Burden: A Single Center Study Jumean, M.F.
 2014
 33 4S p. S202-S203
2 p.
 artikel
761 Surgical Treatment of Chronic Thromboembolic Pulmonary Hypertension: from Transplantation to Endarterectomy D’Armini, A.M.
 2014
 33 4S p. S312-
1 p.
 artikel
762 Survival Following Heart Transplantation in Patients with Transthyretin Amyloid Cardiomyopathy Selby, V.N.
 2014
 33 4S p. S177-S178
2 p.
 artikel
763 Survival Predictors in Ventricular Assist Device Patients with Prior Extra-Corporeal Life Support: Selecting Appropriate Candidates Maxhera, B.
 2014
 33 4S p. S247-
1 p.
 artikel
764 Survival Results in Patients Aged of 60 Years and Older in France Cantrelle, C.
 2014
 33 4S p. S63-S64
2 p.
 artikel
765 Switch From Twice-Daily Tacrolimus (Prograf) To Once-Daily Prolonged-Release Tacrolimus (Advagraf) in Lung Transplantation Jaksch, P.
 2014
 33 4S p. S67-S68
2 p.
 artikel
766 Systemic Inflammation in End-Stage Heart Failure Patients Undergoing Different Axial-Flow Left Ventricular Assist Devices Botta, L.
 2014
 33 4S p. S62-
1 p.
 artikel
767 Systolic Blood Pressure on Discharge from LVAD Insertion Is Associated with Future Stroke Nassif, M.E.
 2014
 33 4S p. S133-
1 p.
 artikel
768 Tacrolimus in Heart Transplant Recipients With Chagas Disease. Initial Experience Favaloro, R.R.
 2014
 33 4S p. S262-
1 p.
 artikel
769 Tacrolimus Pharmacokinetic Modeling Predicts Dose Requirement in Pediatric Heart Transplant Recipients Taylor, B.
 2014
 33 4S p. S115-
1 p.
 artikel
770 Targeted Myocardial Gene Expression Profiling By RNA Sequencing Dhar, K.
 2014
 33 4S p. S76-
1 p.
 artikel
771 Technique for Pediatric En Bloc Lung Transplantation with Bronchial Artery Revascularization Orr, Y.
 2014
 33 4S p. S224-
1 p.
 artikel
772 Teen Pocket PATH: A Randomized Pilot of a Mobile Health Application To Improve Adherence Among Adolescent Solid Organ Transplant Recipients Shellmer, D.A.
 2014
 33 4S p. S32-
1 p.
 artikel
773 Ten-Year Comparison of Prospective Intervention Trials After Heart Transplantation: Tacrolimus/Mycophenolate Mofetil Versus De-Novo Low-Dose Tacrolimus/Sirolimus Guethoff, S.
 2014
 33 4S p. S144-
1 p.
 artikel
774 Terbutaline for Treatment of Sinus Node Dysfunction Following Heart Transplantation Doligalski, C.T.
 2014
 33 4S p. S115-
1 p.
 artikel
775 The Alteration of MiR-326 and MiR-142-3p Expressions during Immune Activation Is Positively Correlated with Graft-protective Cytokine TGF-beta Dewi, I.S.
 2014
 33 4S p. S253-S254
2 p.
 artikel
776 The ‘Blood Transfusion Effect’ in Lung Transplantation - Striking Evidence for an Old Hypothesis in an Unlikely Setting Siemeni, T.
 2014
 33 4S p. S189-S190
2 p.
 artikel
777 The Change in Pulmonary Vascular Resistance After LVAD Implantation - Can It Aid in Predicting Postimplantation Survival? Cikes, M.
 2014
 33 4S p. S263-
1 p.
 artikel
778 The Clinical Impact of Atrial Fibrillation in Patients with the HeartMate II Left Ventricular Assist Device Enriquez, A.D.
 2014
 33 4S p. S193-
1 p.
 artikel
779 The Columbia Experience of 163 Patients with Venoarterial Extracorporeal Membranous Oxygenation for Refractory Cardiogenic Shock Mundy, L.
 2014
 33 4S p. S38-S39
2 p.
 artikel
780 The Combination of Liver Biopsy With MELD-XI Scores for Post-Heart Transplant Outcome Prediction in Patients With Advanced Heart Failure and Suspected Liver Dysfunction Farr, M.A.
 2014
 33 4S p. S157-
1 p.
 artikel
781 The Development of De Novo Donor Specific Antibodies Following Community Acquired Respiratory Virus Infection after Lung Transplantation: A Novel Association Ainge-Allen, H.W.
 2014
 33 4S p. S159-S160
2 p.
 artikel
782 The Diastolic Pulmonary Gradient as a Predictor of Adverse Outcomes in Patients With Acute Decompensated Heart Failure Selby, V.N.
 2014
 33 4S p. S40-
1 p.
 artikel
783 The Duration of Donor CD4 T Cell Chimerism Following Human Lung Transplantation Is Not Affected By Human Leukocyte Antigen and Natural Killer Cell Alloreactivity Gjorgjimajkoska, O.
 2014
 33 4S p. S255-
1 p.
 artikel
784 The Effect of Cold and Warm Ischemia Time on Survival After Lung Transplantation in a Large National Cohort Lannon, J.D.
 2014
 33 4S p. S94-
1 p.
 artikel
785 The Effect of Donor-Derived Herpes Viruses on Lung Transplant Recipient Survival Strah, H.
 2014
 33 4S p. S288-
1 p.
 artikel
786 The Effect of Medication Regimens on Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients Moffett, B.S.
 2014
 33 4S p. S226-
1 p.
 artikel
787 The Effect of Pulsatile and Nonpulsatile Flow on Cerebral Perfusion in Patients with LVADs Cornwell, W.K.
 2014
 33 4S p. S144-
1 p.
 artikel
788 The Effects of Hydrogen Inhalation on Non-Beating Heart Donor Lung During Ex Vivo Lung Perfusion Haam, S.
 2014
 33 4S p. S49-
1 p.
 artikel
789 The EXPAND Lung International Trial to Evaluate the Safety and Effectiveness of the Portable Organ Care System (OCS™) Lung for Recruiting, Preserving and Assessing Expanded Criteria Donor Lungs for Transplantation Van Raemdonck, D.
 2014
 33 4S p. S17-S18
2 p.
 artikel
790 The Feasibility of Extracoporeal Membrane Oxygenation Support for Inter-Hospital Transport and Bridge To Lung Transplantation Kim, D.
 2014
 33 4S p. S261-
1 p.
 artikel
791 The Growing Impact of Lung Transplant (LTX) on Survival for Patients with Cystic Fibrosis (CF) Stewart, P.
 2014
 33 4S p. S227-S228
2 p.
 artikel
792 The Heart Mate Risk Score Correlates with Mortality in an Unselected Mixed Cohort of Heart Mate II and Heart Ware LVAD from a Single Large Volume Center Adamo, L.
 2014
 33 4S p. S88-S89
2 p.
 artikel
793 The Impact of Air Pollution on Outcome After Lung Transplantation in Europe Verleden, S.E.
 2014
 33 4S p. S42-
1 p.
 artikel
794 The Impact of Anemia on Survival in Pulmonary Arterial Hypertension Ramani, G.
 2014
 33 4S p. S229-S230
2 p.
 artikel
795 The Impact of Aortic Valve Opening Status on Bleeding and Thrombotic Risk in Patients with CF-LVAD Levin, A.P.
 2014
 33 4S p. S194-
1 p.
 artikel
796 The Impact of Baseline Renal Dysfunction on Patient Outcomes after Implantation of Chronic Mechanical Circulatory Support Devices Anthony, C.
 2014
 33 4S p. S200-
1 p.
 artikel
797 The Impact of Concomitant Left Ventricular Non-Compaction (LVNC) with Congenital Heart Disease (CHD) on Peri-Operative Outcome Ramachandran, P.
 2014
 33 4S p. S225-
1 p.
 artikel
798 The Impact of Coronary Artery Disease on Lung Transplantation Outcomes Jones, M.O.
 2014
 33 4S p. S80-
1 p.
 artikel
799 The Impact of Incomplete Pulmonary Fissures of Living Lobar Lung Transplant Donors on Bronchial Stenosis of Lung Recipients Sugimoto, S.
 2014
 33 4S p. S295-
1 p.
 artikel
800 The Impact of LVAD Program Volume and Transplant Status on Cost, Quality, and Survival in in the UHC Database 2010-2012 Silvestry, S.C.
 2014
 33 4S p. S35-S36
2 p.
 artikel
801 The Impact of Primary Caregivers on Long-term Outcomes after Lung Transplantation Mollberg, N.M.
 2014
 33 4S p. S45-
1 p.
 artikel
802 The Impact of Recurrent Readmissions on the Cost of LVAD Therapy Lietz, K.
 2014
 33 4S p. S73-
1 p.
 artikel
803 The Impact of Right Atrial Pressure on Outcomes in Children with Advanced Heart Failure Alexander, P.M.
 2014
 33 4S p. S305-
1 p.
 artikel
804 The Impact of VA ECMO on LV Function Dickstein, M.
 2014
 33 4S p. S246-
1 p.
 artikel
805 The Impella Device Offers Superior Survival in Acute Cardiogenic Shock Lemaire, A.
 2014
 33 4S p. S251-
1 p.
 artikel
806 The Importance of Airway and Vascular Parameters in Cellular Ex Vivo Lung Perfusion Assessment of the Donor Lung Okamoto, T.
 2014
 33 4S p. S256-S257
2 p.
 artikel
807 The Incidence of Solid Tumours After Heart Transplantation Has Not Declined in the Last Decade. Data from the Spanish Post-Heart Transplant Tumor Registry Crespo-Leiro, M.G.
 2014
 33 4S p. S136-
1 p.
 artikel
808 The Initial Results of Implantable Rotary Blood Pumps from New Center in Istanbul, Turkey Kucukaksu, S.
 2014
 33 4S p. S265-
1 p.
 artikel
809 The INSPIRE Lung International Trial Evaluating the Impact of Portable Ex-vivo Perfusion Using the Organ Care System (OCS™) Lung Technology on Routine Lung Transplant Outcomes Warnecke, G.
 2014
 33 4S p. S72-
1 p.
 artikel
810 The Lung Transplant Program in Saudi Arabia. Unique Differences and Challenges Nizami, I.
 2014
 33 4S p. S265-
1 p.
 artikel
811 The Necessity of the Caregiver in LVAD Therapy: Time for Introspection and Change? Lee, E.H.
 2014
 33 4S p. S220-
1 p.
 artikel
812 The New Normal: A Bourdieusian Examination of Living Into Young Adulthood Being a Paediatric Heart Transplant Recipient Mauthner, O.
 2014
 33 4S p. S222-
1 p.
 artikel
813 The NOVEL Lung Trial One-Year Outcomes Sanchez, P.G.
 2014
 33 4S p. S71-S72
2 p.
 artikel
814 The Positive Impact of Early Cardiac Rehabilitation on Long Term Survival in Cardiac Transplant Recipients Rosenbaum, A.
 2014
 33 4S p. S277-S278
2 p.
 artikel
815 The Predictive Power of Invasive Hemodynamics and MELD Scores in Ambulatory Patients With Advanced Heart Failure Kato, T.S.
 2014
 33 4S p. S169-
1 p.
 artikel
816 The Prevalence of the Frailty Syndrome in Advanced Heart and Lung Failure Carter, D.
 2014
 33 4S p. S125-S126
2 p.
 artikel
817 The Proceed II International Heart Transplant Trial with the Organ Care System (OCS™) Technology Ardehali, A.
 2014
 33 4S p. S118-
1 p.
 artikel
818 The Prognostic Role of Cardiac Power Indices in Advanced Chronic Heart Failure Grodin, J.L.
 2014
 33 4S p. S39-
1 p.
 artikel
819 The PROSPECT Registry of Pulmonary Arterial Hypertension (PAH): Description of Patients Who Transitioned From Inhaled Prostacyclin to Intravenous Epoprostenol Farber, H.W.
 2014
 33 4S p. S149-
1 p.
 artikel
820 The Risk Associated With Renal Dysfunction in Chronic Heart Failure Is Restricted Primarily To Patients With Neurohormonal Activation Cheng, S.J.
 2014
 33 4S p. S51-
1 p.
 artikel
821 The Risk of Prior Chest Radiation Therapy in Patients Who Undergo Heart Transplantation Yu, Z.
 2014
 33 4S p. S170-S171
2 p.
 artikel
822 The Role of Donor Age and Gender on Survival after Heart Transplantation Weber, D.J.
 2014
 33 4S p. S63-
1 p.
 artikel
823 The Role of Recipient BMI and Age on Survival after Heart Transplantation Weber, D.J.
 2014
 33 4S p. S91-
1 p.
 artikel
824 The Role of the Complement System in Pulmonary Dysfunction Among Traumatic Brain Injured Donors Weber, D.J.
 2014
 33 4S p. S49-
1 p.
 artikel
825 The Role of Ventricular Reconditioning in Weaning From Continuous-Flow Ventricular Assist Devices Frazier, O.H.
 2014
 33 4S p. S204-
1 p.
 artikel
826 The Scientific Impact of the Annual Meeting of the International Society for Heart & Lung Transplantation Schibilsky, D.
 2014
 33 4S p. S9-
1 p.
 artikel
827 The Ubiquitin Ligase Mule Is Required for the Maintenance of Normal Cardiac Function Hauck, L.
 2014
 33 4S p. S165-
1 p.
 artikel
828 The UK Retrieval Team “Scout” Pilot Programme Lannon, J.D.
 2014
 33 4S p. S162-
1 p.
 artikel
829 The Utility of Pulmonary Function Tests in Predicting Pulmonary Outcomes Following Destination Therapy Left Ventricular Assist Device Placement Schechter, M.A.
 2014
 33 4S p. S60-
1 p.
 artikel
830 The Utilization of Non-invasive Echocardiographic Indices in Estimating Pulmonary Capillary Wedge Pressure in Heart Transplant Patients Chamsi-Pasha, M.A.
 2014
 33 4S p. S285-
1 p.
 artikel
831 Thioredoxin-1 Priming: A Novel Strategy to Induce Tolerance in a Rat Model of Lung Transplantation Hu, H.
 2014
 33 4S p. S259-
1 p.
 artikel
832 Thirty-Day Cardiopulmonary Support with a Novel Portable Pediatric Artificial Pump-Lung Liu, Y.
 2014
 33 4S p. S19-S20
2 p.
 artikel
833 Thirty-Five Years of Heart Transplantation at Papworth Hospital: Factors Influencing Outcomes of 25-Year Survivors Prabhu, A.
 2014
 33 4S p. S177-
1 p.
 artikel
834 Thoracic Organ Transplantation for Autoimmune-Mediated Disease Is Not Associated With Detrimental Clinical Outcomes Taimeh, Z.
 2014
 33 4S p. S171-
1 p.
 artikel
835 Thoratec CentriMag® for Temporary Treatment of Refractory Cardiogenic Shock or Severe Cardiopulmonary Insufficiency in Adult and Pediatric Patients: A Systematic Literature Review and Meta-Analysis of Observational Studies Firmin, R.K.
 2014
 33 4S p. S249-S250
2 p.
 artikel
836 Thrombotic Microangiopathy After Lung Transplantation Scheed, A.
 2014
 33 4S p. S186-
1 p.
 artikel
837 Thyroid Hormone Therapy in 63,593 Donors: A Retrospective Review of Heart and Lung Procurement Novitzky, D.
 2014
 33 4S p. S116-
1 p.
 artikel
838 TNF as a Predictor of Myocardial Functional Improvement Induced By Left Ventricular Mechanical Unloading Diakos, N.
 2014
 33 4S p. S156-
1 p.
 artikel
839 Tolerability and Biological Effects of Long Acting Octreotide in Patients With Continuous Flow Left Ventricular Assist Devices Malhotra, R.
 2014
 33 4S p. S241-S242
2 p.
 artikel
840 Tolerance Induction Using Myeloid Progenitor Cells and Autologous HSC Domen, J.
 2014
 33 4S p. S168-S169
2 p.
 artikel
841 Totally Implantable IV Treprostinil Therapy in Pulmonary Arterial Hypertension: Assessment of the Implantation Procedure McElderry, T.
 2014
 33 4S p. S231-
1 p.
 artikel
842 Totally Implantable LVAD: Progress on Portable Wireless Power Delivery System and Results of In-vivo Testing Waters, B.
 2014
 33 4S p. S37-
1 p.
 artikel
843 Towards a Cardiac Allocation Score: Preoperative Stratification Risk and Five Years Survival After Heart Transplantation in a French Cardiac Center Noly, P.
 2014
 33 4S p. S267-
1 p.
 artikel
844 Toxoplasma Serology Mismatch with Increased Mortality? Clarifying the Literature Kittleson, M.
 2014
 33 4S p. S179-S180
2 p.
 artikel
845 Traffic Density Does Not Affect Lung Function in the First Year After Double Lung Transplant Blaikley, J.
 2014
 33 4S p. S295-
1 p.
 artikel
846 Transgenic Human Thrombomodulin Expression Reduces Xenogeneic Thrombosis: a Promising Means of Reducing Pig Lung Xenograft Thrombotic Injury Harris, D.G.
 2014
 33 4S p. S108-
1 p.
 artikel
847 Transmural Heterogeneity of Cellular Level Power Output Is Reduced in Human Heart Failure Haynes, P.
 2014
 33 4S p. S169-
1 p.
 artikel
848 Transplant Activity Around Major US Holidays Chen, S.
 2014
 33 4S p. S267-
1 p.
 artikel
849 Transplanting Patients with VADs Using the Organ Care System Shows Significantly Improved Outcomes: A New Standard of Care? García Sáez, D.
 2014
 33 4S p. S217-S218
2 p.
 artikel
850 Transplant Pharmacist Evaluation Prior To Heart Transplantation Uncovers Medication Noncompliance as a Common Issue Shullo, M.
 2014
 33 4S p. S128-
1 p.
 artikel
851 Two-year Survival After Continuous-flow Left Ventricular Assist Device Versus Heart Transplantation: An Italian Single Centre Perspective Ammirati, E.
 2014
 33 4S p. S218-
1 p.
 artikel
852 Ultrasound-accelerated, Catheter-directed Thrombolysis in the Treatment of LVAD Thrombosis Cole, R.T.
 2014
 33 4S p. S32-
1 p.
 artikel
853 Underweight Patients with Cystic Fibrosis (CF): A Risk Worth Taking Kapnadak, S.G.
 2014
 33 4S p. S185-
1 p.
 artikel
854 Unloading Characterization of the HeartWare HVAD® Pump in a Healthy and Acute Heart Failure Ovine Model Chorpenning, K.
 2014
 33 4S p. S231-S232
2 p.
 artikel
855 Use and Outcomes of Mechanical Circulatory Support for Myocarditis in Pediatric and Adult Patients in the United States Rossano, J.W.
 2014
 33 4S p. S302-S303
2 p.
 artikel
856 Usefulness of ECMO for Cardiac Transplanted Patients Suffering From Early Cardiac Dysfunction Defontaine, A.
 2014
 33 4S p. S282-
1 p.
 artikel
857 Use of ADP Receptor Inhibitor Prior to LVAD Implantation Does Not Increase Risk of Bleeding Tibrewala, A.
 2014
 33 4S p. S244-S245
2 p.
 artikel
858 Use of a Wireless Implantable Hemodynamic Monitor Leads to Reductions in Heart Failure Hospitalizations Among WHO Group II Pulmonary Hypertension Patients Raina, A.
 2014
 33 4S p. S92-
1 p.
 artikel
859 Use of Heavy Drinking Donors in Heart Transplantation is Not Associated With Worse Short- and Medium-Term Mortality Taghavi, S.
 2014
 33 4S p. S267-S268
2 p.
 artikel
860 Use of Various Mechanical Circulatory Support Strategies in End Stage Amyloidosis - A Single Center Experience From an Amyloid Heart Transplant Center Bhimaraj, A.
 2014
 33 4S p. S210-S211
2 p.
 artikel
861 Utility of Octreotide for Treatment of Recurrent Gastrointestinal Bleeding in Continuous-Flow Left Ventricular Assist Device Patients Hashim, T.
 2014
 33 4S p. S245-
1 p.
 artikel
862 Utility of PET/CT Imaging for Identifying LVAD Infections Ramani, G.
 2014
 33 4S p. S197-S198
2 p.
 artikel
863 Utility of Tricuspid Valve Repair at the Time of Left Ventricular Assist Device Implantation Song, H.K.
 2014
 33 4S p. S37-S38
2 p.
 artikel
864 Validation of Peripheral Arterial Tonometry Technique as Surrogate for Central Aortic Pressures Singal, A.
 2014
 33 4S p. S60-
1 p.
 artikel
865 Validation of the Echocardiographic RAMP Test to Diagnose Device Obstruction Holley, C.
 2014
 33 4S p. S215-
1 p.
 artikel
866 Veno-arterial Shunting Is Tolerated in a Canine Model of Partial Ventricular Assist Malekan, R.
 2014
 33 4S p. S231-
1 p.
 artikel
867 Venous Thromboembolism in Heart Transplant Patients: Incidence, Clinical Characteristics and Risk Factors Alvarez Alvarez, R.J.
 2014
 33 4S p. S135-S136
2 p.
 artikel
868 von Willebrand Factor Degradation with an LVAD Occurs via Two Distinct Mechanisms: Mechanical Demolition and Enzymatic Cleavage Bartoli, C.R.
 2014
 33 4S p. S23-
1 p.
 artikel
869 Wait List Outcomes of Pediatric Patients Bridged to Heart Transplantation on the CF-LVADs Left Ventricular Assist Device Singh, R.K.
 2014
 33 4S p. S18-
1 p.
 artikel
870 Weighted Gene Co-expression Network Analysis Reveals Distinct Interaction Patterns in Failing and Recovering Human Myocardium Topkara, V.K.
 2014
 33 4S p. S142-
1 p.
 artikel
871 What Your Lung Transplant Candidates with Chronic Obstructive Pulmonary Disease (COPD) Want and Expect from Transplant Gries, C.J.
 2014
 33 4S p. S140-
1 p.
 artikel
872 Whole Exome Sequencing: A Novel Strategy to Understand Chronic Lung Allograft Dysfunction (CLAD) Todd, J.L.
 2014
 33 4S p. S140-
1 p.
 artikel
873 Why do Children with Congenital Heart Disease Die on the Waitlist? An Analysis of OPTN Data Richmond, M.E.
 2014
 33 4S p. S149-S150
2 p.
 artikel
874 1-Year Mortality in Adult Congenital Heart Disease Heart Transplant Recipients: Can a Risk Score Be Used To Identify Those at Highest Risk? Burchill, L.J.
 2014
 33 4S p. S121-S122
2 p.
 artikel
875 YKL-40, a Novel Marker of Cardiovascular Complications, Is Related To Kidney Function in Heart Transplant Recipients Przybylowski, P.
 2014
 33 4S p. S280-
1 p.
 artikel
                             875 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland
Toegankelijkheidsverklaring